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Università degli Studi di Padova
Dipartimento di Scienze Chimiche
Corso di Laurea Magistrale in Chimica





Relatore: Dott. Luca Dell’Amico
Supervisore: Dott. Xavier Companyó




È facile comprendere le vicende
umane se si tiene conto che gran
parte dei trionfi e delle tragedie della
storia non sono causati da uomini
irrimediabilmente buoni o cattivi, ma
da uomini che sono
irrimediabilmente umani.




In sintesi organica, tra i più floridi ambiti di ricerca vi è la creazione di nuovi legami
carbonio-carbonio. Il controllo della formazione di legami C-C fornisce infatti nuove
e sempre più complesse classi di molecole. Un’ulteriore sfida è lo sviluppo di nuovi
metodi sintetici che forniscano, in maniera enantioselettiva, centri chirali all-carbon.
Questi centri sono spesso il punto chiave per l’accesso alle sintesi totali di molecole
complesse e di grande valore, quali sono i prodotti naturali. Il crescente interesse
verso la tutela dell’ambiente sta dirigendo sempre più la ricerca verso soluzioni che
rispettino i principi della Green Chemistry: atom economy, solventi meno inquinanti,
condizioni di reazione più blande e utilizzo di risorse rinnovabili. La fotochimica e
l’organocatalisi, co-protagoniste di questo progetto di tesi, sono in pieno accordo con
i principi della Green Chemistry. Lo sviluppo di nuove trasformazioni attivate dalla
luce, assieme all’impiego di catalizzatori organici permettono infatti di lavorare in con-
dizioni più blande e con meno sprechi di energia. Questo progetto di tesi è incentrato
sull’ottimizzazione della reazione di alchilazione allilica, con l’utilizzo di un nucleofilo
non stabilizzato che viene attivato dalla luce. Al momento esistono pochissimi esempi
di alchilazione allilica asimmetrica con nucleofili non stabilizzati, e nessuno di questi
organocatalizzato. Gli elettrofili utilizzati per questo progetto sono i carbonati Morita-
Baylis-Hillman (MBH) derivati dall’isatina, una molecola naturale bioattiva. A partire
dal carbonato racemico, si forma un nuovo centro quaternario all-carbon in maniera
enantioselettiva attraverso una doppia attivazione. L’organocatalizzatore chirale attiva
l’elettrofilo e trasferisce l’informazione chirale, mentre la luce attiva il derivato del 2-
metilbenzofenone per formare l’intermedio come nucleofilo al carbonio non stabilizzato.





The formation of new C-C bonds is among the most thriving fields of research in
synthetic organic chemistry. In fact, novel C-C bond-forming transformations give ac-
cess to new, unprecedented carbon backbones. An even more challenging goal is the
development of synthetic methods able to forge quaternary all-carbon centres in an
enantioselective fashion, that allow the synthesis of complex, valuable molecules like
natural products. The growing attention to environment is now directing research to-
wards greener chemical solutions: atom economy, environmentally friendly solvents,
mild reaction conditions, and the use of renewable resources. Photochemistry and
organocatalysis, the two co-protagonists of this thesis project, are in full agreement
with the principles of Green Chemistry. The development of light-triggered transfor-
mations along with the employment of purely organic chiral catalysts allow milder reac-
tion conditions, thus energy saving. This thesis project is focused on the development
and the optimisation of the asymmetric allylic alkylation reaction, using non-stabilised,
photo-generated nucleophiles. To the best of our knowledge, only very few examples of
asymmetric allylic alkylation with non-stabilised nucleophiles have been reported, and
none of them through an organocatalysed strategy. For this purpose, Morita-Baylis-
Hillman (MBH) carbonates derived from isatin, a biologically active molecule, are se-
lected as electrophiles. Starting from racemic MBH carbonates, quaternary all-carbon
stereocentres are created in an enantioselective fashion via a dual activation strategy.
The chiral organocatalyst activates the electrophile and is responsible for the stereoin-
duction event, while light irradiation activates the 2-methylbenzophenone derivative
to form the photoenol intermediate as non-stabilised C-nucleophile. In addition, the
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Heterocyclic compounds are an important class of organic com-
pounds having a crucial role in both biological and pharmacolog-
ical fields. Isatin (1H-indole-2,3-dione) is a heterocyclic molecule
formed by a six-membered ring fused to a five-membered ring bear-
ing a ketone in αto an amide group. Both rings are planar. The
six-membered ring presents aromatic character, whereas the five-
membered ring possesses an anti-aromatic character. Isatin was
first discovered by Erdmann and Laurent as the oxidation product of indigo. It is
found in humans and other mammals as an endogenous molecule, though its metabolic
pathway is not yet fully understood.1
Figure 1.1: The different functionalisation sites of isatin.2
As shown in Figure 1.1, isatin can be easily functionalised, due to the diversity of
its functionalisation sites, thus a large variety of new compounds can be synthesized
from it. Isatin and its derivatives are known to be biologically active molecules and
are widely used in industry as dyes and for electronics applications.2,3 In particular,
3,3-disubstituted oxindoles are of great value for their biological activity and struc-
tural complexity, and they already found application in the pharmaceutical field,4,5 as
shown in Figure 1.2. Moreover, it has been demonstrated that the 3D arrangement of a
molecule, intended as the sp3 character of the carbon centres, results in an enhancement
of bioactivity. The well-defined 3D structure along with the enhanced conformational
rigidity offer distinctive features for new drug candidates, such as enhanced drug-target
recognition or improved physico-chemical properties. A bigger library of structural iso-
mers and stereoisomers becomes also available, allowing a better fine-tuning of the lig-
and/receptor complementarity, thus affording a better targeting with less side effects.6
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Being isatin a versatile and inexpensive compound, I selected it as starting material
to develop new types of reactivity along with novel functionalisations that can result,
ideally, in a new class of useful compounds.
Figure 1.2: Some examples of bioactive 3,3-disubstituted oxindoles5
1.1 Asymmetric Synthesis
Asymmetric synthesis consists in the selective synthesis of one of the two enantiomers
of a chiral molecule. It is of great importance for preparing the precursors for the total
synthesis of natural products, and for the production of efficient pharmaceuticals. A
chiral molecule is any molecule that does not present a plane of symmetry, and therefore
is not superimposable with its mirror image.7 These two mirror images are called enan-
tiomers and show, in achiral environment, exactly the same properties. Conversely,
in a chiral environment they present different properties, owing to the interactions
with other chiral molecules, called diastereomeric interactions. Later on, in 1832 Jean
Baptiste Biot observed the optical activity of natural D-tartaric acid. Another form
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of tartaric acid was also known with the same properties but no optical activity, and
it was called racemic acid. In 1848 Louis Pasteur separated manually the crystals of
synthetic L- and D-tartrate salts. He observed that the two types of crystals yielded
opposite rotation of plane polarised light, while the mixture of the two would cancel
the optical activity reciprocally. So, chirality was discovered. Chiral molecules that are
the main building blocks of living organisms, such as aminoacids and carbohydrates,
are present in nature in only one of the two enantiomeric forms. This fact causes the
overall intrinsic asymmetry of the living beings, from the right-handedness of the DNA,
to the left position of the heart in human beings.7 Therefore, knowledge and control on
the interactions of chiral molecules in a chiral environment is of vital importance, since
it regards ourselves and everyday life, for instance to develop new and more efficient
bioactive compounds. It is well known that the distinct diastereomeric interactions of
the two enantiomers of a drug with the chiral receptors present in our body can result
in inactivity or even in detrimental side effects for one of the two enantiomers.8
Figure 1.3: The two enan-
tiomers of thalidomide, the
(R)- with antiemetic effect
(top) and the (S)- causing
phocomelia in newborn babies
(bottom)
A sadly famous example of the different biolog-
ical activity of two enantiomers is the case of
thalidomide (shown in Figure 1.3), an antiemetic
drug for pregnant women that was commercialised
in the late ‘50s as a racemic mixture. While
the (R)-enantiomer gave the expected effect, the
(S)-enantiomer was discovered to be a teratogenic
agent, causing thousands of cases of malforma-
tion in new-born babies.9 Thus, this case raised
the attention of the organic chemists on the im-
portance of producing enantiopure pharmaceuticals.
The use of asymmetric synthesis plays nowadays
a crucial role, and developments are constantly
arising. There are different strategies towards
asymmetric synthesis (shown in Figure 1.4): chi-
ral resolution, synthesis from the chiral pool, the
use of chiral auxiliaries and asymmetric cataly-
sis.
Chiral resolution It consists in the separation of a racemic mixture by exploiting
the different physicochemical properties (i.e. solubility) of the diastereomeric
salts of the racemic compound with an enantiopure compound (resolving agent).
This method is useful if both enantiomers are needed, otherwise it has a huge
limitation: since it starts from a racemic mixture, the maximum theoretical yield
of one enantiomer is 50%, while the other 50% is wasted.
Chiral pool A second approach is to start from a readily available enantiopure com-
pound, known as the chiral pool, and derivatise it by using stereospecific trans-
formations. This method also presents important limitations, since there may
not be suitable starting materials for the product of interest or the number of
required steps could be very high, reducing the overall yield of the desired final
product.
Chiral auxiliary The third strategy is the use of chiral auxiliaries, enantiopure molecu-
les that can be easily attached to the achiral substrate, affording an enantiopure
adduct. Then, the intended diastereoselective reaction forges a new stereocentre,
furnishing preferably one of the two possible diastereoisomers. Subsequently, the
chiral auxiliary is removed, affording the enantioenriched product.7 The limita-
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Figure 1.4: Representative examples of chiral resolution (a) and asymmetric synthesis:
from the chiral pool (b), with chiral auxiliary (c) and asymmetric catalysis (this work,
d)
tion of this method is the need of a stoichiometric quantity of the chiral auxiliary.
Moreover, two additional steps are required: the addition of the chiral auxiliary
and the removal after the reaction is completed. These two steps contribute to
lower the overall yield as well as the chemical efficiency of the process.
Asymmetric catalysis The last method consists in the use of a substoichiometric
amount of a chiral compound that has the dual function of substrate activation
and transfer of the chiral information. The enantiopure catalyst interacts with
the inactive substrate, activating it and directing the bond-formation event. Once
the transformation has occurred, the chiral catalyst unbinds and is ready for a
new transformation, affording an enantiomerically enriched product in a single
step, making it possible to amplify the chiral information. This method has
many advantages: it is more general and thus can be applied to a larger variety
of substrates, and the theoretical yield and enantiomeric excess can reach up to
100%. Thus, modern organic synthesis is now focusing on this greener and more
efficient approach to asymmetric synthesis.
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1.2 Catalysis and Organocatalysis
Catalysis consists in the enhancement of the rate of a reaction due to a substoichiometric
amount of a catalyst, that is ideally recovered unaffected at the end of the reaction.10
The action of the catalyst consists in lowering the activation energy of the reaction
through a more advantageous reaction pathway with respect to the non-catalysed re-
action. Catalysts can be broadly divided into:
• Transition-metals based catalysts: historically the most widely used, for the di-
versity of metal centres and the possibility to finetune the metals’ properties by
changing their ligands. There are some issues regarding the lability, the toxicity
and the waste disposal for this type of catalysts.
• Biocatalysis: the most selective and efficient since they work at physiological
conditions. However, it is the most difficult to use from a synthetic perspective
due to their cost, as well as their great mechanistic complexity.
• Organocatalysis: consists in the use of small purely organic molecules to acti-
vate substrates, such as phosphines, secondary and tertiary amines, carbenes,
thioureas or phosphoric acids, amongst others.
Organocatalysis is a relatively recent field, even though it is known that it had a key
role in the formation of prebiotic molecules and in the generation of homochirality in
living beings.10 The main goal of modern organocatalysis is the use of organic catalysts
in asymmetric synthesis. Asymmetric catalysis makes use of enantiopure catalysts that
create diastereomeric interactions with the substrate, so that the formation of one of
the two enantiomers will be kinetically favoured, resulting in an enantiomeric enrich-
ment of the desired product. The origins of organocatalysis can be dated back to 1912,
when Bredig reported the addition of HCN to aromatic aldehydes 10 catalysed by cin-
chona alkaloids (Figure 1.5). The cyanohydrin product 12 was obtained in opposite
asymmetric induction by switching from quinine (8) to quinidine (9), albeit in low
enantiomeric excesses (<10% ee).11
Figure 1.5: The organocatalysed addition of HCN to aldehydes, discovered by Bredig
and Fiske in 1912.
In recent years, asymmetric organocatalysis has experienced a fast-growing interest
for its numerous advantages. Organic catalysts are generally more stable and less
toxic with respect to their organometallic counterparts. In addition, they are usually
commercially available and less expensive. Stability, in particular, makes the reaction
conditions more accessible, increasing the reproducibility and operational simplicity.12
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Furthermore, since either they are mostly obtained from the chiral pool and they are
easily modified in order to fine-tune their stereoelectronic properties, organocatalysts
are particularly suitable for asymmetric synthesis. For instance, the addition of bulky
groups commonly increases the efficiency of the asymmetric induction via steric shield-
ing; the addition of hydrogen-bond donor or acceptor moieties improves the direction-
ality and the tightness of the interaction in the transition state; while electron-donating
or electron-withdrawing groups might enhance the nucleophilicity and electrophilicity
of the catalyst, respectively. A paradigmatic example of organocatalyst is L-proline, a
natural aminoacid which contains a pyrrolidine ring. The nucleophilic secondary amine
moiety is able to condense with carbonyls to form the reactive enamine intermediate,
while the chiral carboxylic acid residue is able to transfer the chiral information during
the bon-formation event. The availability of both enantiomers and the numerous possi-
bilities of functionalisation has made proline one of the most used organocatalysts, since
its first appearance in 1971 in the Hajos-Parrish-Eder-Sauer-Wiechert reaction.13,14
In 2000, List, Lerner and Barbas used proline as catalyst for the intermolecular asym-
metric aldol reactions between aromatic aldehydes and α-enolisable ketones. Further,
they postulated the dual activation of proline to both the nucleophile and the elec-
trophile, operated by the secondary amine and the carboxylic acid respectedly.15
Figure 1.6: The mechanism of activation of the asymmetric aldol reaction by proline.
In the same year, MacMillan’s group developed an imidazolidinone catalyst derived
from phenylalanine, for a highly enantioselective Diels-Alder cycloaddition between
α,β-unsaturated aldehydes with dienes.16
Figure 1.7: Structure of the chiral activated iminium ion, formed upon condensation
between the α,β-unsaturated aldehyde with the imidazolidinone catalyst.16
In this case, the catalyst forms a hindered chiral iminium ion, directing preferentially the
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nucleophilic attack by the Si -face of the electrophilic conjugated π-system. In Figure
1.7 is shown the original example reported by MacMillan and co-workers. Remarkably,
these two reports are currently considered as the birth of modern organocatalysts. Fur-
ther, they set the basis of the two main activation modes in covalent aminocatalysis: the
HOMO-rising15 and the LUMO-lowering16 strategies. Another remarkable advantage
of organocatalysis is predictability: there are few, well-known activation mechanisms,
and they are generalisable to a large number of different reactions.17 Although they
can be grouped using different criteria, the most common classification is according the
nature of the interaction between the substrate and the catalyst, between covalent and
non-covalent activation.18
• Covalent activation: the catalyst binds covalently to the substrate generating
the activated species. After the bond-formation step, the activated species is
hydrolysed forming the final product while releasing the catalyst. This class of
activation includes enamine activation (HOMO-rising), iminium ion activation
(LUMO-lowering) or SOMO activation, amongst others.
• Non-covalent activation: the catalyst activates the substrate and directs the bond-
formation event via non-covalent interaction such as hydrogen-bonding or ion
pairing. Examples of non-covalent catalysts are chiral thioureas and squaramides,
phase-transfer catalysis or chiral Brønsted acid.
Figure 1.8: Examples of covalent and non-covalent activation in organocatalysis.19
It should be noticed that many organocatalysts present multiple active sites and con-
sequently can simultaneously activate both the nucleophile and the electrophile, as
already mentioned for proline (see Figure 1.6). These are known as multifunctional
catalysts.20 Moreover the same catalyst can work under different activation modes,
depending on the substrate.
1.2.1 Cinchona Alkaloids
Cinchona alkaloids are natural bioactive molecules, extracted from the bark of the
Cinchona trees, historically used as medicaments. They are constituted by two main
parts: a quinoline ring and a substituted chiral 1-azabicyclo[2.2.2]octane moiety, joined
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together through a stereogenic carbon that bears a secondary alcohol.21 In organic syn-
thesis they are often employed as chiral Brønsted and Lewis bases. They are available
as two pseudoenantiomeric forms, that usually provide opposite enantiomers with al-
most identical enantioselectivity.22 Their high versatility brought to a great library of
synthetic derivatives. Of particular interest is the β-isoquinidine 2c, that contains an
oxazatwistane ring. This ring, having less conformational flexibility, presents reduced
steric hindrance at the quinuclidine nitrogen, thus increasing the basicity and the nu-
cleophilicity of the tertiary amine.22 Moreover, the removal of the methyl group in 2c
affords β-isocupreidine 2a, that contains an aromatic hydroxy group that either can
hydrogen-bond with the substrate or can be further functionalised to tune the catalyst
properties. Thus, β-isocupreidineis a multifunctional catalyst which presents a highly
nucleophilic tertiary amine and a hydrogen-bond donor site. In the present thesis work,
β-isocupreidine has been proven as the best performing catalyst.
Figure 1.9: Natural cinchona alkaloids and their synthetic derivatives.
1.3 Asymmetric Allylic Alkylation
Asymmetric allylic alkylation is considered nowadays one of the most powerful strate-
gies to make C-C bonds enantioselectively. It was first developed in 1965 by Tsuji
and co-workers, using a stoichiometric allylpalladium complex as the activated elec-
trophile.23 Subsequently, the group of Trost24 improved the method adding triph-
enylphosphine as a ligand on palladium, making the transformation catalytic. Further,
in 1977 the same group developed the first asymmetric version,25 by using Pd together
with a chiral phosphine ligand.
Figure 1.10: The Tsuji-Trost reaction.
The great innovation with respect to other asymmetric metal-catalysed reactions lies
in the fact that, from racemic, achiral or prochiral starting materials, the transfor-
mation converges quantitatively to only one enantiomer of the product.26 This is due
to the loss of the stereocentre in the formation of the electrophilic π-allyl complex.
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Thus, the stereoinducing event is controlled by the chiral palladium complex catalysts.
Trost also identified two different mechanisms according to the different nature of the
nucleophile: stabilised or “soft” nucleophiles maintain the stereochemistry of the com-
plex, because they directly attack the allylic position, while unstabilised, or “hard”
nucleophiles attack the palladium centre, resulting in an inversion of the stereochem-
istry with respect to the starting material (Figure 1.11). Several synthetically useful
transformations have been established using stabilised nucleophiles, while the efficient
use of non-stabilised nucleophiles is much more challenging and to date only very few
examples are reported.
Figure 1.11: The different mechanisms of Pd-catalysed allylic alkylation, according to
the nature of the nucleophile.
In 2002 the first organocatalytic asymmetric allylic substitution was reported by Kim,27
using Baylis-Hillman acetates as the allylic electrophiles, and cinchona alkaloids as chi-
ral catalysts (Figure 1.12). Interestingly, a double selectivity is operative in this trans-
formation. Firstly, the kinetic resolution in the formation of the diastereomeric salt
XIII with the chiral catalyst, and subsequently the asymmetric induction in the nucle-
ophile addition step to XIII, that generates the alcohol 14. Two years later, Krische
reported the deracemisation of MBH acetates using a chiral phosphine as catalyst,
obtaining therefore a dynamic resolution in the first step.28
Figure 1.12: The first enantioselective catalytic allylic substitution.
The mechanism, summarised in Figure 1.13, starts with the attack of the tertiary amine
on the alkene moiety of the MBH carbonate 15, ionising the leaving group via an SN2’
mechanism and forming the electrophilic catalytic intermediate XV. Subsequently, the
nucleophile performs a second SN2’ to the allylic position of the catalytic species,
releasing the catalyst which is ready for a new catalytic turnover while furnishing the
final product.29
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Figure 1.13: The SN2’-SN2’ mechanism of the organocatalytic asymmetric allylic alky-
lation.
Since then, extensive study has been done. MBH derivatives are suitable for asymmetric
allylic alkylation and their carbonates and acetates have been widely studied, because
of the facile transformation of the allylic alcohol into a better leaving group. Chen
and co-workers were the first to report in 2010 a highly stereo- and enantioselective
allylic alkylation of isatin-derived MBH carbonates, using β-isocupreidine as the chiral
Lewis base (Figure 1.14).30 Many stabilised nucleophiles have been tested on MBH
carbonates with good results: N-nucleophiles31 also with less nucleophilic partners, like
aromatic amines,32 O-nucleophiles and C-nucleophiles.33–35 So far, only few attempts
with non-stabilised nucleophiles have been reported, all with metal catalysis,36,37 while
there are no reports in organocatalysis.
Figure 1.14: The first organocatalytic asymmetric allylic alkylation forging a quater-
nary all-carbon stereocentre, by Chen and co-workers.
Figure 1.15: Example of asymmetric allylic alkylation with 2-fluoromalonate 19, a
stabilised C-nucleophile.34
1.4 Photochemistry
Photochemistry is intended as the study of chemical reactions and physical changes
resulting from interactions between matter and visible or ultraviolet light.38 The first
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photochemical organic reactions were developed by Paternò in 1909 (Figure 1.16) and
Ciamician in 1912 (Figure 1.17). Ciamician already foresaw the necessity of a replace-
ment of coal and non-renewable resources with the way greener sunlight. His numerous
studies included the reactivity of alcohols and ketones under light irradiation and the
light degradation of terpenes and alkaloids.39
Figure 1.16: The Paternò-Büchi reaction, synthesising an oxetane ring from benzalde-
hyde and an alkene.
Figure 1.17: The photo-induced coupling of benzophenone, discovered by Ciamician.
Photochemistry is a useful tool in organic synthesis, because light irradiation can gen-
erate highly reactive species under mild conditions and with minimum generation of
waste, in accordance with the Green Chemistry principles.40
The main difference between light activation and thermal activation lies in the way the
reactive intermediate is reached. An electronically excited state has approximately the
same configuration of the nuclei as the ground state, but different electronic distribution
and different polarisation, or eventually radical nature. Thus, compared to the ground
state, the excited state is much more energetic. Once excited by light, the molecule
can either undergo back conversion to the ground state or conversion to a different
intermediate, thus exploring different energetic levels and different configurations. On
the other hand, thermal generation of an intermediate is usually a slow step, that re-
quires to overcome a high activation barrier. Thus, generally, more harsh conditions
are required, such as high/low pH, high temperature, high pressure, etc. Instead, a
photochemical reaction starts already from a highly energetic state (the electronically
excited state of the molecule), and the process of formation of the intermediate is just
an exothermic decay with a very low energy barrier (Figure 1.18). In fact, photochemi-
cal reactions are not generally influenced by experimental conditions, provided that the
experimental conditions themselves do not change the nature of the excited state. This
feature is particularly useful because the intermediates can be generated and reacted
in cryogenic conditions, and even labile compounds can react, due to the fact that nor
heat neither harsh chemicals are commonly needed for photochemical substrate activa-
tion.41 Nevertheless, photochemistry presents some disadvantages, since light is a new
reaction variable to be controlled. Thus, the main relevant parameters are irradiation
wavelength and light intensity. The irradiation wavelength can be carefully controlled
relatively easily, using lamps with a broader or sharper emission spectrum, according
to reaction requirements. On the other hand, light intensity is a bit more tricky since it
depends on the lamp type, that should also be changed frequently in order to grant re-
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Figure 1.18: Schematic representation of the thermal and photochemical generation of
a general reactive intermediate, which subsequently evolves to product formation.
producibility, on the material of the reaction vessel (it is preferable if it is not absorbing
at the working wavelength), on the shape of the vessel, on the distance from the light
source, on the solvent (which can also absorb at the working wavelength), and on the
concentration. According to the Lambert-Beer law II0 = e
−kλl, the intensity I0 of light
will decrease exponentially with the thickness l of the solution, irradiating efficiently
only the most superficial layers, thus making the up-scaling of photochemical reactions
an open challenge. Moreover, there could be other species in solution absorbing at the
same wavelength, like for instance, the product itself. This is the so called inner filter
effect, and it is a problem since it reduces the photon flux to the reacting mixture.
Also, the product can undergo secondary unwanted side-reactions or light degradation.
These problems can be partly resolved by choosing an adequate wavelength at which
the product does not absorb, or by subtracting the product from light irradiation as
soon as it is formed, for instance with the aid of a microfluidic reactor, which will be
introduced in Section 1.5.
1.4.1 Photoenol
The reactivity of photogenerated hydroxy-o-quinodimethanes was discovered in 1961
by Yang and Rivas. By irradiation of a 2-methylbenzophenone 1 solution in methanol-
d4 with a Hg arc lamp, deuteration occurred, and the deuterium atoms were only found
in the benzylic position, while no deuteration occurred in the case of the reaction in
dark.42 Subsequently, the photoenol intermediate was trapped in a Diels-Alder [4+2]
cycloaddition with acetylene dicarboxylate 23 (shown in Figure 1.19).
Figure 1.19: The first reaction using a photoenol intermediate, reported by Yang and
Rivas in 1961.
Figure 1.20 shows the mechanism of photoexcitation of the 2-methylbenzophenone 1.
Light irradiation generates the diradical excited state that quickly turns from singlet
to triplet state via inter system crossing. The triplet state decays via intramolecu-
lar hydrogen abstraction to two diradical conformers. The (Z )-form is short lived and
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rapidly undergoes [1,5]-sigmatropic H-shift, affording the initial 2-methylbenzophenone.
Conversely, the (E )-form is more stable and as a consequence can react with an elec-
trophile.
Figure 1.20: The light-triggered photoenol formation of 2-methylbenzophenone.
Photoenol intermediates have only been studied and used in recent years. In 2001
it was used by Jinsung’s group for intermolecular and intramolecular cycloadditions.
This reaction afforded key building blocks for the total synthesis of hamigerans, which
possess bioactive properties.43
Figure 1.21: Intermolecular and intramolecular cyclisation of the photoenol.
In 2015 Murakami reported a light-driven carboxylation of hydroxy-o-quinodimethanes
with CO2. Light irradiation generates the reactive species that is then able to trap
CO2 through a [4+2] transition state, where CO2 acts as the dienophile. After internal
rearrangement, the carboxylated product 29 is formed. Beyond the benefits of CO2
fixation, these carboxylated products are also valuable building blocks for the synthesis
of benzodiazepines.44
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Figure 1.22: Light-driven carboxylation of 2-methylbenzophenones.
In 2016, Melchiorre’s group developed the first organocatalytic asymmetric Diels-Alder
cycloaddition using the photoenol intermediate as a diene. The authors employed a
chiral H-bond donor catalyst in order to make the dienophile more reactive towards
cycloaddition, trapping the photogenerated species enantioselectively.45 The catalyst of
choice was a bifunctional thiourea-amine derived from natural cinchona alkaloids. This
catalyst was involved in two different mechanisms of stereocontrol: it was responsible
of the asymmetric induction and, by partially quenching the photoenol activity, it
minimised the background racemic reaction.
Figure 1.23: The first asymmetric Diels-Alder reaction with a photogenerated hydroxy-
o-quinodimethane.
One year later, Melchiorre’s group again reported the enantioselective conjugate ad-
dition of 2-methylbenzophenone 1 to α,β-unsaturated aldehydes 33.46 The chiral sec-
ondary amine catalyst 34 generates a conjugated iminium ion which then undergoes
Michael addition with the photoexcited 2-methylbenzophenone.
Figure 1.24: The conjugate addition of photogenerated hydroxy-o-quinodimethanes to
α,β-unsaturated aldehydes.
Later on, Ye and co-workers reported a Michael addition of 2-methylbenzophenone
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derivatives to enones, that afford new quaternary all-carbon stereocentres 38 (Figure
1.25).47 Remarkably, photogenerated hydroxy-o-quinodimethanes were proven to trap
also activated imines via Mannich reaction with moderate enantioselectivity,48 and can
also act as a nucleophile in aldol reactions.49
Figure 1.25: The Michael addition of photogenerated hydroxy-o-quinodimethanes to
enones.
However, to the best of our knowledge, photoenol has not yet been used in the asym-
metric allylic alkylation reaction.
1.5 Microfluidics in Photochemical Reactions
Microfluidics deals with the behaviour of fluids that are constrained in small capillaries.
A microfluidic setup for synthetic applications is typically constituted by eight different
parts shown in Figure 1.26: fluid and reagent delivery, mixer, the reactor, quenching,
back pressure regulation, collection, analysis and purification.50
Figure 1.26: General scheme of a microfluidic reactor.50
Even though not all the reactions are suitable for microfluidic setup, it presents some
advantages with respect to the traditional batch setup:
• increased surface to volume ratio
• more efficient heat transfer
• rapid and efficient mixing
• higher pressure that allows high temperature with low-boiling solvents
• easy up-scaling
Further, the implementation of microfluidic reactor in light-triggered transformations
becomes a powerful way to enhance the reactivity of photochemical reactions. The ad-
ditional advantages of microfluidic photoreactor compared to photochemical reactions
in batch are:
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• better light penetration, granting a uniform illumination
• shorter reaction times
• enhanced reproducibility
• less side reactions
• possibility to avoid detrimental over irradiation
In fact, irradiation can cause to the reaction mixture many side reactions, such as degra-
dation of the product or of the starting material and formation of undesired products.
In continuous flow, the reaction mixture is irradiated only for the time it remains in-
side the reactor. Conversely, in batch the whole reaction mixture is illuminated for the
whole time, and slower side reactions can take place in the meantime. Moreover, in
the classical batch conditions, illumination reaches only the most superficial molecules,
thus giving heterogeneous irradiation to the reaction mixture.51 The small diameter
of the capillary permits a better light penetration on the whole reaction mixture, and
pressure ensure a suitable mixing of the reactants. All these properties generally lead
to shorter reaction times as well as improved selectivity with respect to batch pho-
toreactions. Also, the continuous flow enables the easy up scaling of the optimised
reaction. Furthermore, being the distance between the light and the reaction mixture
constant, and being the flow rate controllable, the results are much more accurate and
reproducible.
On the other hand, the limitation of microfluidics is the necessity of all reaction compo-
nents to be soluble in the selected solvent, since the mixture needs to be homogeneous
to avoid clog inside the capillary.
Recently, our laboratory has demonstrated how microfluidic conditions enhance the
yield of diverse photochemical reactions, reducing the formation of undesired side-





2.1 Development of the Reaction
The aim of this thesis project is the installation of an all-carbon quaternary stereocen-
tre at allylic positions of isatin-derived MBG carbonates 3, trhough the asymmetric
allylic alkylation with non-stabilised C-nucleophiles. In order to do this, a dual acti-
vation strategy is used: light for the generation of the reactive C-nucleophile 1a and a
chiral catalyst for the stereoselective activation of the electrophile IIIa. As previously
mentioned in Section 1.3, asymmetric allylic alkylation with non-stabilised nucleophiles
(with pKa >25) is still an open challenge, especially in Lewis-base catalysed transfor-
mations. Allylic alkylation is a reaction that is particularly suitable for asymmetric
synthesis purposes. In fact, from a racemic starting material, the catalyst activation
is stereoconvergent towards the common electrophilic intermediate IIIa. Thus, the
steric hindrance of the chiral Lewis base governs the stereodetermining event to yield
the enantioenriched benzylated product 4a. The activation mechanism of MBH car-
bonates with tertiary amine catalysts is well documented and it is reported also for
isatin-derived MBH carbonates. On the other hand, the light-triggered activation of
2-methylbenzophenone is also reported and already explained in Section 1.4.
Hence, in the present thesis project, the two activation mechanisms are merged in order
to develop the dual-activated asymmetric allylic alkylation of MBH carbonates 3 with
2-methylbenzophenone derivatives 1 as non-stabilised C-nucleophiles.
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2.2 Synthesis of the Starting Materials
The electrophilic starting materials for this project are synthesised in three steps. The
first one is the N-protection of isatin. NaH deprotonation and subsequent addition of
the corresponding alkyl halide, affords the protected isatin derivative 5 via nucleophilic
substitution.
Subsequently, the N-protected isatin is subjected to Morita-Baylis-Hillman reaction
with different acrylates catalysed by DABCO (41), to obtain the allylic alcohols 6.
The last step is the conversion of the alcohol group into a good leaving group. Thus,
the MBH alcohol 6 is protected with di-tert-butyl dicarbonate in the presence of a
catalytic amount of DMAP, a nucleophilic amine that activates the anhydride towards
the attack of the alcohol.
On the other hand, the nucleophilic starting materials, are syntehsised in two steps.
The first step is Grignard addition to substituted benzaldehyde 42. The obtained
alcohol is directly oxidised to afford the 2-methylbenzophenone derivatives 1.
With the starting materials on hand, the light-triggered catalytic asymmetric allylic
benzylation is set up as follows. The isatin-derived MBH carbonate 3 and the cata-
lyst 2 are weighed in a screw-cap vial equipped with a rubber septum and a magnetic
stirring bar, and the vial is carefully purged with argon. Removal of oxygen is impor-
tant because oxygen quenches the triplet state of the excited 2-methylbenzophenone,
thus lowering the amount of reactive photoenol intermediate. Subsequently, anhy-
drous degassed solvent is added through the septum together with the corresponding
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2-methylbenzophenone pronucleophile 1. Finally, the vial is sealed with parafilm and
irradiated with the suitable light source for the indicated time.
The reaction is initially performed with DABCO as catalyst, in order to synthesise the
racemic sample. This allows to establish the feasibility of the transformation and to find
the suitable conditions of separation in the chiral HPLC. The two enantiomers should
appear as two different peaks with identical area as well as same absorbance spectrum.
Injection of the product obtained with the chiral Lewis base in the same conditions,
presents the same peaks but with different areas, corresponding to the enantiomeric
ratio.
2.3 Optimisation of the Reaction in Batch
Screening of esters and amide-protecting groups in toluene: At the beginning, an ini-
tial screening of the esters (R1) and of the N-protecting groups (R3) was performed.
The selected solvent was toluene, since it was the most widely used in literature for
asymmetric allylic alkylation. Selected results are shown in Table 2.1.
entry R1 R3 3 yield (%) of 4 er of 4
1 Me Me 3a 24 72:28
2 Me Bn 3g 15 75:25
3 Me Boc 3h traces n.d.
4 Me Tr 3i traces n.d.
5 tBu Me 3j 15 82:18
6 tBu Bn 3k 10 76:24
Table 2.1: Screening of the MBH carbonates with different esters and amide-protecting
groups. The yields were calculated by integrating the NMR peaks of the reaction
crude using pyrazine as internal standard. The enantiomeric ratio was determined by
chiral HPLC analysis. Reaction conditions: 0.1 mmol of 3 (1 equiv.), 1a (5 equiv.),
β-isocupreidine (20 mol%) in 1 mL of MeOH were irradiated at 365 nm for 16h.
Although full conversion of the starting material was observed, the yields were in gen-
eral low. Moreover, a remarkable difference in yields between 3a and 3g, and between
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3j and 3k was observed. The low yields can be attributed to a combination of increased
bulkiness of the N-benzyl group and light degradation of both the reagent and the prod-
uct. The addition of another chromophore, such in the case of the benzyl group in 3k,
increases the absorption of the molecule, leading to faster light-degradation. Since the
bulkier amide-protecting groups did not improve the enantiomeric excess, the N-Me
protecting group was chosen for further optimisation.
During the setup of the reaction, upon addition of the cat-
alyst and the MBH carbonate in the vial, a rapid change
of colour from beige to bright orange was observed, which
was attributed to the formation of the activated electrophilic
species IIIa. This could mean that the formation of the elec-
trophilic intermediate is fast and as a consequence its concen-
tration in the reaction course is relevant. At this point, we
attributed the low yields to the degradation of the starting
material in the presence of β-isocupreidine 2a. Therefore, we
focused the attention to study and improve the stability of
the different reaction components in different solvents.
Stability tests in different solvents: The MBH carbonate starting materials 3 were
mixed with 20 mol% of β-isocupreidine 2a in different solvents and monitored by semi-
continuous NMR experiments. 3k was proven to be quite stable in toluene, thus the
low yield must be attributed to other causes, for instance light decomposition. The ex-
Figure 2.1: The graphic shows the stability of the MBH carbonate with catalytic
amounts of β-ICD 2a versus time in different solvents. Monitored by 1H NMR us-
ing pyrazine as internal standard. Reaction conditions: 0.1 mmol of 3 (1 equiv.),
β-isocupreidine (20 mol%) in 1 mL of solvent.
ceptional stability in toluene with respect to the other starting materials is attributable
to the high steric hindrance of the tert-butyl ester that makes the molecule less reac-
tive. Conversely, 3g was proven to be unstable, with about 80% of remaining starting
material after only 4 hours. Also 3a is unstable in toluene and polar aprotic solvents.
Methanol was the only solvent in which 3a was stable (see Figure 2.1), thus it was
chosen for further optimisation.
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Blank tests: The reaction was tested without light and without catalyst. No reactivity
was observed, as reported in Table 2.2, thus confirming the proposed dual activation
mechanism of the reaction.
entry solvent deviation from standard conditions yield (%) of 4a er of 4a
1 MeOH no catalyst 2a n.r. n.d.
2 MeOH no light irradiation n.r. n.d.
Table 2.2: Blank reactions. The yields were calculated by integrating the NMR peaks
of the reaction crude using pyrazine as internal standard. The enantiomeric ratio was
determined by chiral HPLC analysis. Reaction conditions: 0.1 mmol of 3 (1 equiv.),
1a (5 equiv.), β-isocupreidine (20 mol%) in 1 mL of MeOH were irradiated at 365 nm
for 16h.
Screening of chiral Lewis bases: Subsequently, different catalysts were screened, and β-
isocupreidine was confirmed to be the best both in terms of reactivity and asymmetric
induction. Results are shown in Table 2.3.
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entry catalyst 2 yield (%) of 4a er of 4a
1 2a 66 70:30
2 2b 24 65:25
3 2c 31 63:37
4 2d 55 70:30
5 2e 21 70:30
6 2f 12 70:30
7 2g 23 59:41
8 2h 10 53:46
9 2i n.r. n.d.
10 2j n.r. n.d.
11 2k n.r. n.d.
12 2l n.r. n.d.
13 2n n.r. n.d.
14 2o n.r. n.d.
15 2p n.r. n.d.
15 2qa n.r. n.d.
17 2ra n.r. n.d.
18 2s 4 n.d.
Table 2.3: Screening of different catalysts. The yields were calculated by integrating the
NMR peaks of the reaction crude using pyrazine as internal standard. The enantiomeric
ratio was determined by chiral HPLC analysis. Reaction conditions: 0.1 mmol of 3 (1
equiv.), 1a (5 equiv.), catalyst 2 (20 mol%) in 1 mL of MeOH were irradiated at 365
nm for 16h. aThese catalysts were kindly provided by professor Jose L. Vicario.54
Screening of other alcoholic solvents: Commonly, in the asymmetric allylic alkylation
with activated C-nucleophiles, the tBuO− formed upon decomposition of the leaving
group deprotonates the C-pronucleophile before the C-C bond forming step, as shown
in Figure 2.2. Conversely, in this reaction, the tBuO− present in solution is quenched
after the C-C bond formation. Thus, the reaction was tested in other alcoholic sol-
vents in order to rule out a possible inhibition of the reactivity by the strong base in
solution.
Figure 2.2: General reaction mechanism of asymmetric allylic alkylation with an acidic
nucleophile. The tBuOH from the leaving group is necessary to activate the nucleophile.
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entry solvent yield (%) of 4a er of 4a
1 MeOH 66 70:30
2 iPrOH 31 70:30
3 tBuOH 45 71:29
4 hexafluoroisopropanol n.r. n.d.
Table 2.4: Screening of other alcoholic solvents. The yields were calculated by inte-
grating the NMR peaks of the reaction crude using pyrazine as internal standard. The
enantiomeric ratio was determined by chiral HPLC analysis. Reaction conditions: 0.1
mmol of 3 (1 equiv.), 1a (5 equiv.), β-isocupreidine (20 mol%) in 1 mL of solvent were
irradiated at 365 nm for 16h.
Hexafluoroisopropanol is probably too acidic and it can deactivate the catalyst 2a by
protonation of the quinuclidine nitrogen. In fact, no reaction was observed (Table ??,
entry 4). Low reactivity was observed with iPrOH and tBuOH. Therefore, MeOH was
employed for further optimisation.
Effect of temperature: In catalytic asymmetric transformations, temperature usually
plays a crucial role in the determination of the enantiomeric excess. Low temperature
reduces the energy input to the system, disfavouring the formation of the diastereoiso-
meric intermediate with higher activation energy. This is verified also in our case,
but with no significant improvement in the enantiomeric ratio and, in return, with a
considerable loss in yield. The standard conditions (20◦C) are used for further investi-
gations.
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entry temperature yield (%) of 4a er of 4a
1 20◦C 66 70:30
2 0◦C 42 72:28
3 -12◦C 30 75:25
Table 2.5: Effect of temperature. The yields were calculated by integrating the NMR
peaks of the reaction crude using pyrazine as internal standard. The enantiomeric
ratio was determined by chiral HPLC analysis. Reaction conditions: 0.1 mmol of 3 (1
equiv.), 1a (5 equiv.), β-isocupreidine (20 mol%) in 1 mL of MeOH were irradiated at
365 nm for 16h.
Screening of miscellaneous reaction parameters: Other relevant parameters such as light
source, catalyst loading, and solvent mixtures were investigated. Selected results are
shown in Table 2.6.
entry 2a (mol%) solvent light time (h) yield (%) of 4a er of 4a
1 20 MeOH 9W 365nm bulb 16 66 70:30
2 20 MeOH HP LED 50mA 16 65 70:30
3 20 MeOH HP LED 350mA 4 81 70:30
4 20 MeOH/Toluene 9:1 HP LED 350mA 4 70 70:30
5 20 MeOH/Cyclohexane 9:1 HP LED 350mA 4 65 71:29
6 20 MeOH/DCM 9:1 HP LED 350mA 4 71 71:29
7 20 MeOH/THF 9:1 HP LED 350mA 4 60 70:30
8 10 MeOH HP LED 350mA 3 80 [78]a 70:30
9 5 MeOH HP LED 350mA 3 50 70:30
10 1 MeOH HP LED 350mA 3 12 n.d.
11b 20 MeOH HP LED 350mA 3 51 70:30
Table 2.6: Screening of miscellaneous conditions. The yields were calculated by inte-
grating the NMR peaks of the reaction crude using pyrazine as internal standard. The
enantiomeric ratio was determined by chiral HPLC analysis. Reaction conditions: 0.1
mmol of 3 (1 equiv.), 1a (5 equiv.), β-isocupreidine in 1 mL of solvent were irradiated
at 365 nm. a[Isolated yield]. bUsing 2 equiv. of 1a.
As it can be seen in Table 2.6, the best result in terms of yield was obtained using a
10% catalyst loading, with a high-power 365nm LED 350mA of intensity. Being this
the best result, and having no remarkable improvements on the enantiomeric excess,
the conditions of entry 8 are used for further investigation.
Screening of the ester groups: Various ester groups were examined in MeOH to evaluate
whether this substitution has an impact on the enantiomeric excess. Results are shown
in Table 2.7.
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entry R1 3 yield (%) of 4 er of 4
1 Me 3a 80 [78]a 70:30
2 Et 3e 61 [57]a 70:30
3 Hex 3l 33 64:36
4 tBu 3j 5 85:15
5 Bn 3m 34 64:36
Table 2.7: Screening of the ester groups. The yields were calculated by integrating the
NMR peaks of the reaction crude using pyrazine as internal standard. The enantiomeric
ratio was determined by chiral HPLC analysis. Reaction conditions: 0.1 mmol of 3 (1
equiv.), 1a (5 equiv.), β-isocupreidine (10 mol%) in 1 mL of MeOH were irradiated at
365 nm. a[Isolated yield].
Unfortunately, increasing the bulkiness of the ester group only affects the reactivity,
and the enantiomeric ratio is increased only with the tBu group. However, the hin-
drance of the tBu ester derivative 3j reduces drastically the reactivity, yielding only
5% of product.
After extensive screening of all the variables, the following conclusions were deduced:
• Dual activation of both the nucleophile and the electrophile is needed in order to
have the intended reactivity
• A protic solvent is needed to stabilise the reactants
• Steric hindrance of the ester and the amide-protecting group do not affect the
asymmetric induction significantly. Only with the tert-butyl ester the enan-
tiomeric ratio is improved, but with a considerable loss in yield.
• β-isocupreidine is the best catalyst
• Lower catalyst loading (10%) increases the yield, compared with the initial 20%
• The enantiomeric ratio does not vary significantly upon variation of all the reac-
tion parameters and even the temperature dependence is very slight. The only
remarkable variations are obtained upon variation of the chiral catalyst.
Based on literature reports and on the relevant information gained during the extensive
optimisation studies, a first hypothesis on the reaction mechanism is formulated (shown
in Figure 2.3). In this scenario the catalytic resting state is the activated electrophile
IIIa. The attack of the photogenerated nucleophile Ia in the allylic position is the rate
determining step. The generated photoenol Ia is very low in concentration during the
reaction course. In fact, it has a short lifetime and it tends to go back to the initial
state 1a. Therefore, we decided to characterise the intermediate IIIa.
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Figure 2.3: Proposed mechanism.
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2.4 Characterisation of the Catalytic Intermediate
As highlighted by the previous reports present in literature, the asymmetric allylic
alkylation of isatin-derived MBH carbonates 3 catalysed by β-isocupreidine and other
cinchona alkaloids usually furnishes good reactivity with excellent enantiomeric ex-
cesses.30,55,56 Conversely, for the present transformation, despite the extensive opti-
misation studies, the asymmetric induction could not be improved higher than 70:30
er. However, the reaction furnished the product in fair yields up to 78%. In order to
understand the reasons of the moderate enantioselectivity, the study on the catalytic
intermediate and the reaction mechanism was carried out. The second SN2’ (that is the
attack by the photoenol and thus the C-C bond formation) is the rate-determining step,
which can be demonstrated by the fact that the catalytic intermediate IIIa is the cat-
alytic resting state (its concentration is high and constant during the reaction course).
Therefore, the reason for the moderate stereoinduction could be the E/Z isomerisation
Figure 2.4: Proposed mechanism with the possible isomerisation mechanisms.
of the catalytic intermediate IIIa: if the catalytic intermediate has the possibility to
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isomerise, the catalyst will end up shielding the opposite prochiral face, affording the
opposite enantiomer. In this scenario, we hypothesise that the isomerisation can be
mediated by the tBuO− generated upon leaving group ionisation or owing to the light
irradiation. The reaction scheme, with the two possible isomerisation paths, is shown
in Figure 2.4.
Despite all the attempts to synthesise and isolate the species IIIa were unsuccessful,
by mixing the MBH carbonate 3a and β-isocupreidine 2a in equimolar amount directly
inside an NMR tube MeOH-d3 it was possible to form in situ the catalytic speciesIIIa.
Subsequently, a series of NMR experiments, including 1H NMR, 13C NMR HSQC,
HMBC and NOESY NMR were acquired in order to characterise it. The NOESY
experiment was acquired both in MeOH-d4 and MeOH-d3. Herein the different char-
acterisation experiments are reported with corresponding assignments.
Figure 2.5: In situ formation of the catalytic species IIIa.
Figure 2.6: Characterisation of the catalytic species IIIa in methanol-d3.
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Figure 2.7: Characterisation of the catalytic species IIIa in methanol-d3.
Figure 2.8: HSQC spectrum of IIIa in methanol-d3. The HSQC experiment shows the
correlation between carbon and hydrogen. In blue CH2, in red CH and CH3. Carbons
not showing any correlation peaks are the quaternary carbons.
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Figure 2.9: NOESY spectrum of IIIa in methanol-d3, with assignments. In green the
contact between H12 of the methyl ester and H7 is shown.
Figure 2.10: NOESY spectrum of IIIa in methanol-d4, with assignments. The peak of
proton 4, previously hidden by 13, is now visible due to deuteration.
The Nuclear Overhauser Effect Spectroscopy experiment shows through-space contacts
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of protons. Results show that, at least at the initial time, only the (E )-isomer is
formed selectively (see the NOESY spectra in Figure 2.9 and 2.10). The experiment in
methanol-d4 allows to distinguish the signals arising from proton 4 from the ones of the
allylic proton 13. Thus, the NOESY spectra confirm no evidence of formation of the
(Z )-IIIa. This is consistent with the bulkiness of the catalyst, and with the previous
successful reports of asymmetric allylic alkylation with β-isocupreidine as a catalyst.
From the HSQC spectrum (Figure 2.8, the allylic protons 13 could be correlated with
the allylic carbon 13. This carbon has a chemical shift which is typical of the sp3
character. Thus, the electrophilic intermediate IIIa is the species present in solution
at equilibrium, rather than the ylide IVa. Methanol is acidic enough to protonate the
free tBuO−. This explains the bright orange colour of the solution of IIIa in methanol,
due to the extended conjugation upon nucleophilic attack of the catalyst.
Figure 2.11: Allylic ylide IVa (left) and electrophilic catalytic intermediate IIIa (right).
Next, the kinetics of formation and isomerisation of the catalytic intermediate IIIa
was studied. The starting material 3a and β-isocupreidine 2a were mixed together in
1:1 ratio in methanol-d4.
1H NMR spectra were acquired at regular intervals of time.
The formation of IIIa was monitored by the disappearance of the peak at 1.34 ppm,
corresponding to the tBu signal of 3, along with the appearance of the new peak of the
ionised tBuO− at 1.25 ppm. Once the salt was completely formed, it was irradiated
with a 9W 365nm lamp and its evolution was checked by 1H NMR. Two observations
can be made:
• The area of the multiple peaks at 6.5 ppm decreases smoothly, until there is
only one doublet. In fact, the multiplet is made by two different protons, and
one is the allylic proton 13, that exchanges with methanol-d4, deuterating and
disappearing within approximately 180 minutes. The disappearance of the second
allylic proton 13 at 4.7 ppm can also be seen in Figure 2.12.
• Upon 2h irradiation, no significant change in the chemical shifts is detected (see
bottom spectrum of Figure 2.12).
The disappearance of the allylic protons 13 of IIIa is the proof that there is a pro-
ton exchange between the solvent and the allylic protons of IIIa. Conversely, light
isomerisation could not be detected after irradiation for 2h. Thus, the experiment of
irradiation of IIIa is repeated, this time in methanol-d3 in order to avoid deuteration
of the allylic protons. 3a and 2a are mixed together in stoichiometric amount in the
NMR tube, waiting until complete formation of IIIa before starting the acquisition.
If a substantial change in the chemical shift is detected upon irradiation of the NMR
tube, this would be the proof that light is responsible of the isomerisation of the cat-
alytic species. As expected, with methanol-d3 the allylic protons 13 could be detected.
Unfortunately, the catalytic species IIIa decomposed under light irradiation before any
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Figure 2.12: 1H NMR spectra of the catalytic intermediate at different times in
methanol-d4. In yellow the starting material 3a can be seen. In blue, H4 of 3a,
that is superimposed with H4 of IIIa (green). In red, the disappearance of the allylic
protons 13 of IIIa, due to deuteration.
light-induced isomerisation could be observed.
From this series of experiments some conclusions can be made:
• There is proton exchange between the acidic proton of methanol and the catalytic
intermediate IIIa
• Isomerisation happens but it cannot be detected by NMR experiments because
the catalytic intermediate decomposes under light
• Base-mediated isomerisation cannot be excluded
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Characterisation of the MBH-DABCO bromide salt IIIa’: In order to detect the iso-
merisation of the catalytic species, and to exclude the role of the strong base in the
isomerisation of the catalytic intermediate, a similar system with a non-basic coun-
teranion was studied. Adapting the procedure from a reported study,57 the bromide
Figure 2.13: Synthesis of the MBH-DABCO bromide salt (E)-IIIa’.
salt IIIa’ derived from the isatin MBH alcohol and DABCO (see Figure 2.13) was syn-
thesised. The MBH alcohol 6a was treated with aqueous HBr 48% to yield the bromide
(E )-7a The bromide 7a was then treated with DABCO and (E )-IIIa’ was isolated in
45% yield as an orange solid.
The salt was fully characterised and its photochemical isomerisation was studied by
semi-continuous 1H NMR experiments.
Figure 2.14: 1H NMR characterisation of IIIa’ in methanol-d3. In the absence of
irradiation it is only present as the (E )-isomer.
43
Figure 2.15: 13C NMR characterisation of IIIa’ in methanol-d3.
Figure 2.16: Isomerisation of the salt IIIa’ upon light irradiation, followed by 1H NMR.
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Figure 2.17: Isomerisation of the salt IIIa’ upon irradiation. In the graph, the area
of the peaks corresponding to the methyl ester (H12) are plotted against illumination
time.
This time isomerisation between (E)-IIIa’ and (Z )-IIIa’ could be observed. In 140
min of irradiation the diastereomeric ratio changes from E/Z = 98:2 to 85:15, reaching
37:63 after 13h (shown in Figure 2.16 and Figure 2.17). Remarkably, no isomerisation
was observed in the absence of irradiation after 16h, thus confirming the key role of
light in the determination of the enantiomeric ratio. It is reasonable to think that, in
the reaction conditions, intermediate IIIa formed with β-isocupreidine has the same
behaviour, although the effect may be mitigated by the increased steric hindrance of
β-isocupreidine.
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2.5 Optimisation of the Reaction in Flow
Proven that the reaction mixture was homogeneous and stable in methanol without ir-
radiation (as previously shown in Figure 2.1, in Section 2.3), the present light-triggered
asymmetric allylic benzylation was optimised into a microfluidic photoreactor. The
results are shown in Table 2.8.
Figure 2.18: Scheme of the microfluidic photoreactor used in this experiment.
Figure 2.19: Picture of the microfluidic photoreactor used in this experiment.
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Concentration β-ICD 2a (mol%) 2-MBP 1a Residence time Conversion NMR yield
0.1 M 20% 5 eq.
60 min 92% 39%
40 min 89% 52%
30 min 86% 50%
0.05 M 20% 5 eq.
40 min f.c. 47%
30 min f.c. 55%
15 min 71% 46%
10 min 53% 34%
0.05 M 10% 5 eq.
50 min 89% 45%
40 min 91% 44%
30 min 67% 65% [65%]a
0.05 M 5% 5 eq.
50 min f.c.% 24%
40 min 84% 25%
30 min 68% 29%
20 min 57% 29%
10 min 36% 26%
0.05 M 20% 2 eq.
30 min 87% 58%
25 min 51% 58%
20 min 60% 39%
15 min 82% 38%
0.05 M 10% 3 eq.
40 min 60% 46%
35 min 60% 50%
30 min 53% 43%
20 min 48% 37%
Table 2.8: Screening of reaction conditions into a microfluidic photoreactor. Yield and
conversion were calculated by integrating the NMR peaks of the reaction crude using
pyrazine as internal standard. a[Isolated yield].
In terms of catalyst loading, the best results were obtained with 10 mol% of 2a. While a
5 mol% of catalyst loading was not enough to grant the satisfying reaction turnover, 20
mol% of 2a leads to high conversion values but lower NMR yields. As already seen in the
previous section, the electrophilic intermediate IIIa decomposes under light irradiation,
therefore high catalyst loading causes faster decomposition and reduces the overall effi-
ciency of the transformation. Variation on the concentration of 2-methylbenzophenone
also changed the results significantly: being the nucleophilic attack of the photoenol the
slow step of the catalytic cycle, the more 2-methylbenzophenone 1a present in solution,
the faster is the reaction. Moreover, higher concentration of 1a in solution has also the
beneficial function of inner filter, partially absorbing light irradiation and preventing
over irradiation of the catalytic species IIIa.
Although, the optimal conditions in the microfluidic photoreactor (shown in bold in
Table 2.8) could not improve the 78% yield obtained in batch.
Covalent catalysis is not usually suitable for flow setup, because covalent activation is
generally slower than non-covalent activation. In fact, in literature there are very few
reports dealing with photoreactions in flow that take place via covalent activation. It
should be noticed that the use of 10 mol% of catalyst loading means that the catalyst
has to make 10 turnovers inside the microfluidic photoreactor.
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Another reason could be the different emission spectra of the two lights used for the
batch and for the flow, both with the maximum centred on 365nm. While the high-
power LED used for batch reactions presents a much sharper emission band, the 9W
lamp has a broader spectrum, as shown in Figure 2.20. Since both the catalytic in-
termediate and the product absorb at that given wavelength, it is possible that the
product and/or the catalytic intermediate decompose faster under the irradiation of
9W 365nm bulb.
Figure 2.20: Emission spectra of the 9W 365nm lamp used in the flow setup (top) vs
High-Power 365nm LED used in the batch setup (bottom).
This hypothesis is supported by the values of conversion: as expected, the quantity of
starting material decreases when the residence time is increased (which corresponds to
the exposure time to the light). In return, the yield does not increase with the same
trend and, conversely, it decreases notably if the residence time is too long. UV-vis
spectra were acquired for all the species present in solution (Figure 2.21), and both the
catalytic species IIIa and the product 4a are absorbing at the working wavelength.
In addition, although the 9W lamp used in the microfluidic setup is about seven times
less intense than the HP LED used in batch, the light irradiation is much more efficient
in microfluidic conditions. In fact, as already mentioned in the introductory chapter,
the capillary grants a more efficient and homogeneous illumination to the whole reacting
mixture, but this implies also a faster degradation of the light-sensitive species present
in solution.
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Figure 2.21: Absorption spectra of isatin MBH carbonate 3a (red, 10−3M), catalytic
intermediate IIIa (green, 10−3M) and benzylated product 4a (blue, 10−3M) in MeOH.
The operative wavelength used in the present work (365 nm) is shown as a dotted black
line.
Figure 2.22: Absorption spectrum of 2-methylbenzophenone 1a (10−3M) in MeOH.
The UV-vis spectrum confirms the high absorbance of the catalytic species IIIa at
the working wavelength, while 3a does not absorb at the working wavelength. In
addition, the product 4a is absorbing at the operative wavelength and could also
decompose under light exposition. In fact, the benzylated product contains the 2-
methylbenzophenone moiety, so the absorbance spectrum will be similar to that of
1a.
2.6 Scope
The best conditions found during the optimisation of the batch reaction are: 1 equiva-
lent of MBH carbonate 3 (0.1mmol), 5 equivalents of 2-methylbenzophenone derivative
1 and 10% of β-isocupreidine in 1mL degassed methanol (0.1M) at room tempera-
ture using HP LED 350mA. With these conditions the generality of the reaction was
investigated.
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Figure 2.23: Scope of the reaction. The enantiomeric ratios were determined by chi-
ral HPLC analysis. Reaction conditions: 0.1 mmol of 3 (1 equiv.), 1 (5 equiv.), β-
isocupreidine 2a (10 mol%) in 1 mL of argon-degassed methanol were irradiated at 365
nm for 3h. aIrradiated overnight.
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The best results were obtained starting from the unsubstituted substrate (product 4a)
and from the 5-F isatin-derived MBH carbonate (product 4c). It is reasonable to
think that these substrates are enough electron-poor towards the nucleophilic attack
and therefore the reaction is faster, leading to higher yields. With a chlorine in the
6-position of the aromatic ring of the electrophile the reaction also works quite well
(4b). Weak electron-donating groups are also tolerated, albeit with lower yield (4d).
Esters and N-protecting groups only affect the reactivity and not the enantioselectivity,
as it can be seen for products 4j and 4k and as demonstrated in previous optimisa-
tion studies. Conversely, electron-withdrawing groups on the nucleophile decrease both
the reactivity and the enantiomeric ratios. The lower reactivity is attributed to the
less nucleophilic character of the nucleophiles containing electron-withdrawing groups.
Surprisingly, very low reactivity was observed with the extendedly conjugated 4’-MeO-
2-methylbenzophenone (product 4e) which in principle should be more nucleophilic in
virtue of the resonance properties of the methoxy group on the aromatic ring. Instead,
as expected, a methoxy group in the MBH carbonate aromatic ring inhibits the reactiv-
ity, and no reaction was observed (4l). All the new benzylated products were isolated
and fully characterised by 1H, 13C NMR and HRMS. The enantiomeric ratios were
measured using chiral HPLC analysis on the purified samples. Specific optical rotation
were measured for all the isolated benzylated products (4a-4d and 4f -4k). Compound
4a was crystallised and structure was resolved by XRD (CCDC 1960705). The absolute
configuration of the benzylated products was determined as (R) by TD-DFT calcula-





Organocatalysis and photochemistry are gaining nowadays more and more attention
for their lower impact on the environment and their lower hazardous nature. In this
thesis project, the first light-triggered, Lewis-base catalysed allylic benzylation of isatin-
derived MBH carbonates is reported.
The reaction affords a wide set of 3,3-disubstituted oxindoles bearing an all-carbon
benzylated quaternary stereocenter with good yields up to 78% and moderate enan-
tioselectivities around 40%. The reaction was optimised for batch and for microfluidic
continuous synthesis. Remarkably, this represents one of the few examples of asym-
metric light-triggered tranformations via covalent catalysis in flow.
The hypothesised dual activation by light and the chiral catalyst is proven. Light irra-
diation excites the 2-methylbenzophenone pronucleophile 1a to generate the activated
nucleophile Ia, while β-isocupreidine activates MBH carbonate 3a towards the gener-
ation of the reactive electrophilic catalytic intermediate IIIa (Figure 3.1).
Figure 3.1: The dual activation mechanism of the present photoactivated asymmetric
allylic benzylation.
Mechanistic investigation revealed that the reasons for the moderate asymmetric in-
duction was the E/Z photoisomerisation of the intermediate IIIa, the catalytic resting
state (Figure 3.2). The light-induced isomerisation and the decomposition of IIIa are
verified by NMR experiments and are supported by the UV-vis spectrum of IIIa, that
shows high absorption at the working wavelength.
Base-mediated isomerisation was ruled out after NMR experiments on a similar system
with an inert counteranion instead of the strong base tBuO−. Although allylic proton
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Figure 3.2: Isomerisation of the intermediate IIIa
exchange with the solvent is evidenced by the fact that in methanol-d4 they slowly
exchange with deuterium, the tBuO− ionised upon formation of IIIa is not the reason
of the isomerisation.
There is still room for improvement. A recent study58 used a 700nm laser to excite
the 2-methylbenzaldehyde by two-photon absorption. This process generated the cor-
responding photoenol intermediate through an identical mechanism to the photoeno-
lisation of 2-methylbenzophenone. The intermediate XLIV reacted in a [4+2] cy-
cloaddition manifold with maleimides (Figure 3.3). Being the two-photon absorption
a non-linear effect, a very intense light source was required. Therefore, this could be a
possible solution to overcome the light-induced isomerisation of the intermediate IIIa,
provided that the intermediate itself does not undergo two-photon absorption neither
isomerisation upon laser illumination.
Figure 3.3: A double photon absorption of 2-methylbenzaldehyde 44 is used to generate




Instruments: NMR spectra were recorded on Bruker 400 Avance III HD equipped with
a BBI-z grad probehead 5mm. The chemical shifts (δ) for 1H and 13C are given in ppm
relative to residual signals of the solvents (CDCl3@ 7.26 ppm
1H NMR, 77.16 ppm
13C NMR; MeOD@ 3.31 ppm, 4.87 ppm 1H NMR, 49.00 ppm 13C NMR). The fol-
lowing abbreviations are used to indicate the multiplicity: s, singlet; d, doublet; t,
triplet; q,quartet; m, multiplet; bs, broad signal. NMR yields were calculated by using
pyrazine as internal standard. High-Resolution Mass Spectra (HRMS) were obtained
using Waters GCT gas chromatograph coupled with a time-of-flight mass spectrome-
ter (GC/MS-TOF) with electron ionization (EI) or MicroTOF II (Bruker Daltonics):
HPLC-MS-TOF (ESI). Chromatographic purification of products was accomplished us-
ing flash chromatography on silica gel (SiO2, 0.04-0.063 mm) purchased from Machery-
Nagel, with the indicated solvent system according to the standard techniques. Thin-
layer chromatography (TLC) analysis was performed on pre-coated Merck TLC plates
(silica gel 60 GF254, 0.25 mm). Visualization of the developed chromatography was
performed by checking UV absorbance (254nm) as well as with aqueous potassium per-
manganate solutions. Organic solutions were concentrated under reduced pressure on
a Büchi rotary evaporator.
Materials: Commercial grade reagents and solvents were purchased at the highest com-
mercial quality from Sigma Aldrich, Alfa Aesar or Fluka and used as received, unless
otherwise stated.
4.1 General procedure for preparation of substituted 2-methylbenzo-
phenones
The benzaldehyde derivative 42 (1 eq.) is dissolved in dry THF under argon atmo-
sphere. The mixture is cooled to 0◦C and a 0.5M solution of 43 (1.2 eq.) is slowly
added. The mixture is left to warm up to room temperature. After completion, the
reaction is quenched with water and extracted with AcOEt. The organic phase is dried
with MgSO4 and dried in vacuum. The crude is then dissolved in dry DCM and MnO2
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(7 eq.) is added under Ar atmosphere. The mixture is refluxed for 10h. The mix-
ture is then filtered, washed with DCM and purified by flash chromatography to afford
compound 1.45
4.2 General procedure for preparation of N-methyl-isatins
Substituted isatin 39 (1 eq.) is dissolved in DMF under N2 atmosphere. NaH (1.2
eq.) is added at 0◦C and stirred for 5 minutes. Methyl iodide (1.2 eq.) is then added
slowly. After completion, the reaction is quenched with water and extracted with ethyl
acetate. The organic layer is dried over MgSO4 and dried in vacuum. The product 5
is precipitated from DMF by addition of water and filtered in vacuum.59,60
1-methyl-1H-indole-2,3-dione 5a: 1H NMR (400 MHz,
Chloroform-d) δ 7.59 (qd, J = 7.5, 1.0 Hz, 2H), 7.12 (td,
J = 7.5, 0.8 Hz, 1H), 6.90 (d, J = 7.9 Hz, 1H), 3.24 (s, 3H). The
NMR peaks are in accordance with what previously reported in
literature.61
1-methyl-1H-6-chloro-indole-3-dione 5b: 1H NMR (300 MHz,
Chloroform-d) δ 7.53 (d, J = 8.0 Hz, 1H), 7.09 (dd, J = 7.9, 1.7
Hz, 1H), 6.89 (d, J = 1.7 Hz, 1H), 3.23 (s, 3H). The NMR peaks
are in accordance with what previously reported in literature.62
1-methyl-1H-5-fluoro-indole-3-dione 5c: 1H NMR (200 MHz,
Chloroform-d) δ 7.42 – 7.27 (m, 2H), 6.86 (dd, J = 9.5, 3.4 Hz,
1H), 3.26 (s, 3H). The NMR peaks are in accordance with what
previously reported in literature.63
1,5-dimethyl-1H-indole-2,3-dione 5d: 1H NMR (200 MHz,
Chloroform-d) δ 7.40 (d, J = 7.8 Hz, 2H), 6.78 (d, J = 8.1 Hz,
1H), 3.23 (s, 3H), 2.34 (s, 3H). The NMR peaks are in accordance
with what previously reported in literature.63
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1-allyl-1H-indole-2,3-dione 5e: 1H NMR (200 MHz, Chloroform-
d) δ 7.58 (qd, J = 7.8, 7.2, 1.2 Hz, 2H), 7.12 (t, J = 7.5 Hz, 1H),
6.89 (d, J = 7.9 Hz, 1H), 5.85 (ddd, J = 22.4, 10.4, 5.4 Hz, 1H),
5.47 – 5.14 (m, 2H), 4.37 (d, J = 5.2 Hz, 2H). The NMR peaks
are in accordance with what previously reported in literature.64
4.3 General procedure for preparation of MBH alcohols
N-protected isatin 5 (1 eq.) is mixed with DABCO (0.5 eq.) and acrylate 40 (5 eq.)
in a vial. After completion, the reaction mixture is purified by flash chromatography
and dried in vacuum to afford the final product 6.65
methyl 2-(3-hydroxy-1-methyl-2-oxoindolin-3-yl)acrylate 6a:
1H NMR (200 MHz, Chloroform-d) δ 7.35 (td, J = 7.7, 1.4
Hz, 1H), 7.24 – 7.14 (m, 1H), 7.04 (td, J = 7.5, 1.0 Hz, 1H),
6.87 (d, J = 7.8 Hz, 1H), 6.56 (s, 1H), 6.39 (s, 1H), 3.64 (s,
3H), 3.26 (s, 3H). The NMR peaks are in accordance with
what previously reported in literature.66
methyl 2-(6-chloro-3-hydroxy-1-methyl-2-oxoindolin-3-
yl)acrylate 6b: 1H NMR (200 MHz, Chloroform-d) δ
7.11 (d, J = 8.2 Hz, 1H), 7.02 (dd, J = 8.2, 1.7 Hz, 1H), 6.87
(d, J = 1.9 Hz, 1H), 6.57 (s, 1H), 6.40 (s, 1H), 3.66 (s, 3H),
3.24 (s, 3H). The NMR peaks are in accordance with what
previously reported in literature.67
methyl 2-(5-fluoro-3-hydroxy-1-methyl-2-oxoindolin-3-
yl)acrylate 6c: 1H NMR (300 MHz, Chloroform-d) δ
7.02 (td, J = 8.8, 2.6 Hz, 1H), 6.93 (dd, J = 7.6, 2.4 Hz, 1H),
6.77 (dd, J = 8.4, 4.1 Hz, 1H), 6.55 (s, 1H), 6.39 (s, 1H),
3.63 (s, 3H), 3.22 (s, 3H). The NMR peaks are in accordance
with what previously reported in literature.68
methyl 2-(5-methyl-3-hydroxy-1-methyl-2-oxoindolin-3-
yl)acrylate 6d: 1H NMR (200 MHz, Chloroform-d) δ
7.14 (d, J = 9.3 Hz, 1H), 7.01 (s, 1H), 6.76 (d, J = 7.8 Hz,
1H), 6.56 (s, 1H), 6.39 (s, 1H), 3.65 (s, 3H), 3.24 (s, 3H),
2.30 (s, 3H). The NMR peaks are in accordance with what
previously reported in literature.69
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ethyl 2-(3-hydroxy-1-methyl-2-oxoindolin-3-yl)acrylate 6e: 1H
NMR (200 MHz, Chloroform-d) δ 7.34 (td, J = 7.5, 1.1 Hz,
1H), 7.20 (dd, J = 7.2, 1.0 Hz, 1H), 7.04 (td, J = 7.6, 0.9 Hz,
1H), 6.86 (d, J = 7.8 Hz, 1H), 6.58 (s, 1H), 6.38 (s, 1H), 4.06
(qd, J = 7.2, 2.0 Hz, 2H), 3.25 (s, 3H), 1.14 (t, J = 7.1 Hz,
3H). The NMR peaks are in accordance with what previously
reported in literature.70
methyl 2-(3-hydroxy-1-allyl-2-oxoindolin-3-yl)acrylate 6f: 1H
NMR (200 MHz, Chloroform-d) δ 7.32 (d, J = 6.3 Hz, 1H),
7.20 (d, J = 7.0 Hz, 1H), 7.03 (t, J = 7.7 Hz, 1H), 6.87 (d, J
= 7.6 Hz, 1H), 6.57 (s, 1H), 6.41 (s, 1H), 6.04 – 5.75 (m, 1H),
5.48 – 5.15 (m, 2H), 4.56 – 4.18 (m, 2H), 3.64 (s, 3H). The
NMR peaks are in accordance with what previously reported
in literature.68
4.4 General procedure for preparation of MBH carbonates
MBH alcohol 6 is dissolved in dry dichloromethane under N2 atmosphere, in a round-
bottomed flask. Di-tert-butyl dicarbonate (1.5 eq.) and DMAP (0.05 eq.) are mixed
together in dichloromethane and then added to the reaction mixture at 0◦C. The reac-
tion is quenched with HCl 2M and extracted with dichloromethane. The organic layer
is dried over MgSO4 and subsequently purified by flash chromatography to afford the
final product 3.71
methyl 2-(1-methyl-3-tert-butoxycarbonyloxy-2-oxoindolin-3-
yl)acrylate 3a: 1H NMR (200 MHz, Chloroform-d) δ 7.33
(td, J = 7.7, 1.4 Hz, 1H), 7.18 (d, J = 7.5 Hz, 1H), 6.99 (td,
J = 7.5, 1.0 Hz, 1H), 6.85 (d, J = 7.8 Hz, 1H), 6.60 – 6.54
(m, 1H), 6.53 (s, 1H), 3.57 (s, 3H), 3.29 (s, 3H), 1.34 (s, 9H).
The NMR peaks are in accordance with what previously
reported in literature.71
methyl 2-(3-((tert-butoxycarbonyl)oxy)-6-chloro-1-methyl-
2-oxoindolin-3-yl)acrylate 3b: 1H NMR (200 MHz,
Chloroform-d) δ 7.09 (d, J = 7.7 Hz, 1H), 6.97 (dd, J
= 7.9, 1.8 Hz, 1H), 6.85 (d, J = 1.6 Hz, 1H), 6.57 (s, 1H),
6.54 (s, 1H), 3.59 (s, 3H), 3.28 (s, 3H), 1.36 (s, 9H). The




oxoindolin-3-yl)acrylate 3c: 1H NMR (200 MHz, Chloroform-
d) δ 7.11 – 6.91 (m, 2H), 6.83 – 6.72 (m, 1H), 6.59 (s, 1H),
6.54 (s, 1H), 3.60 (s, 3H), 3.29 (s, 3H), 1.37 (s, 9H). The
NMR peaks are in accordance with what previously reported
in literature.65
methyl 2-(1,5-dimethyl-3-tert-butoxycarbonyloxy-2-oxoindolin-
3-yl)acrylate 3d: 1H NMR (200 MHz, Chloroform-d) δ 7.13
(d, J = 7.3 Hz, 1H), 7.00 (s, 1H), 6.74 (d, J = 8.1 Hz, 1H),
6.56 (s, 1H), 6.53 (s, 1H), 3.58 (s, 3H), 3.28 (s, 3H), 2.29 (s,
3H), 1.36 (s, 9H). The NMR peaks are in accordance with
what previously reported in literature.65
ethyl 2-(1-methyl-3-tert-butoxycarbonyloxy-2-oxoindolin-3-
yl)acrylate 3e: 1H NMR (200 MHz, Chloroform-d) δ 7.33
(td, J = 7.8, 1.3 Hz, 1H), 7.18 (dd, J = 7.4, 0.8 Hz, 1H),
6.99 (td, J = 7.6, 0.9 Hz, 1H), 6.84 (d, J = 7.8 Hz, 1H), 6.57
(s, 1H), 6.51 (s, 1H), 3.98 (qd, J = 7.2, 4.5 Hz, 2H), 3.29
(s, 3H), 1.34 (s, 9H), 1.09 (t, J = 7.1 Hz, 3H). The NMR
peaks are in accordance with what previously reported in
literature.71
methyl 2-(3-((tert-butoxycarbonyl)oxy)-1-allyl-2-oxoindolin-3-
yl)acrylate 3f: 1H NMR (200 MHz, Chloroform-d) δ 7.38 –
7.26 (m, 1H), 7.19 (d, J = 8.5 Hz, 1H), 6.98 (t, J = 7.5 Hz,
1H), 6.85 (d, J = 8.3 Hz, 1H), 6.54 (d, J = 7.6 Hz, 2H), 6.06
– 5.81 (m, 1H), 5.47 (d, J = 17.2 Hz, 1H), 5.26 (d, J = 10.4
Hz, 1H), 4.56 – 4.28 (m, 2H), 3.57 (s, 3H), 1.35 (s, 9H). The
NMR peaks are in accordance with what previously reported
in literature.65
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4.5 General procedure for allylic benzylation
Figure 4.1: Picture of the reaction setup used in this study
Racemic: MBH carbonate 3 (0.1 mmol, 1 eq.) and DABCO (0.2 eq.) are purged
with Ar in a 4 ml an oven dried screw cap vial. Methanol (1 ml) is added and 2-
methylbenzophenone 1 (5 eq.) is added. The mixture is put under UV light (High
Power LED, 365nm, 0.35A) for 4h. The progress of reaction is checked by NMR with
internal standard pyrazine. The crude is separated by flash chromatography to afford
the final product. The product is dissolved in dichloromethane, filtered and injected in
the chiral HPLC to see the retention time of the two enantiomers.
Chiral: MBH carbonate 3 (0.1 mmol, 1 eq.) and β-isocupreidine (0.1 eq.) are purged
with Ar in an oven dried screw cap vial. Methanol (1 ml) and 2-methylbenzophenone
1 (5 eq.) are added. The mixture is put under light (High Power LED, max λ
365nm, 0.35A) and the reaction is followed by TLC. After completion, the crude is
purified by flash chromatography to yield the final product. The product is dissolved
in dichloromethane, filtered and injected in the chiral HPLC to evaluate the enan-
tiomeric excess.
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4.6 Screening of the reaction conditions for microfluidic setup
Figure 4.2: Scheme of a microfluidic photoreactor
Figure 4.3: Set-up of the microfluidic photoreactor used in this experiment
MBH carbonate 3 and β-isocupreidine 2a are purged with Ar in a vial. Methanol (5
ml) and 2-methylbenzophenone 1 are added. The mixture is injected in a 400µL flow
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reactor in UV light (9W bulb, 365nm, 0.05A) varying the retention time. NMR is used
to qualitatively determine the yield, with pyrazine as an internal standard. The results
of the optimisation are shown in Table 4.1
Concentration β-ICD 2a (mol%) 2-MBP 1a Residence time Conversion NMR yield
0.1 M 20% 5 eq.
60 min 92% 39%
40 min 89% 52%
30 min 86% 50%
0.05 M 20% 5 eq.
40 min f.c. 47%
30 min f.c. 55%
15 min 71% 46%
10 min 53% 34%
0.05 M 10% 5 eq.
50 min 89% 45%
40 min 91% 44%
30 min 67% 65% [65%]a
0.05 M 5% 5 eq.
50 min fc% 24%
40 min 84% 25%
30 min 68% 29%
20 min 57% 29%
10 min 36% 26%
0.05 M 20% 2 eq.
30 min 87% 58%
25 min 51% 58%
20 min 60% 39%
15 min 82% 38%
0.05 M 10% 3 eq.
40 min 60% 46%
35 min 60% 50%
30 min 53% 43%
20 min 48% 37%
Table 4.1: Screening of reaction conditions into a microfluidic photoreactor. Yield and
conversion were calculated by integrating the NMR peaks of the reaction crude using
pyrazine as internal standard. a[Isolated yield].
4.6.1 Upscaling of flow reaction
MBH carbonate 3a (3.5 mmol, 1 eq.) is mixed with β-isocupreidine 2a (0.1 eq.) and
2-methylbenzophe-none 1a (5 eq.) in a round-bottomed flask with 70 ml of methanol.
Ar is bubbled inside the reaction mixture and after 30 minutes purging, the mixture
is put in flow under light (9W 365 nm bulb, λ max=365 nm, 0.05A), with a retention
time of 30 minutes. The crude is purified by flash chromatography, affording 4a with
65% isolated yield.
4.7 Characterisation of the benzylated products
Methyl (R)-2-(3-(2-benzoylbenzyl)-1-methyl-2-oxoindolin-3-
yl)acrylate 4a: Synthesized following the general procedure
described in Section 4.5. The product was obtained as
a red solid after flash chromatography on silica gel using
petroleum ether/EtOAc 9:1 as eluent. Yield 78%; e.r. 70:30
HRMS calculated for [C27H23NO4]+H: 426.1705; found:
426.1705
[α]30D : (−15.7 ± 1.9)◦
1H NMR (400 MHz, Chloroform-d) δ 7.48 – 7.40 (m, 1H), 7.29 – 7.17 (m, 6H),
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7.07 – 6.99 (m, 2H), 6.83 (td, J = 7.7, 1.1 Hz, 1H), 6.65 – 6.61 (m, 1H), 6.52 (s, 1H), 6.43
(d, J = 7.7 Hz, 1H), 6.26 – 6.20 (m, 1H), 6.17 (s, 1H), 4.28 (d, J = 12.7 Hz, 1H), 3.42 (s,
3H), 3.37 (d, J = 12.7 Hz, 1H), 2.91 (s, 3H). 13C NMR (101 MHz, Chloroform-d)
δ 197.38, 177.85, 165.32, 144.33, 140.38, 138.14, 137.32, 135.26, 132.68, 132.58, 130.63,
130.12, 129.93, 129.76, 128.35, 127.76, 127.53, 125.72, 123.54, 122.50, 107.36, 56.11,
51.96, 35.51, 26.10.
HPLC: Phenomenex Lux 5u Cellulose-5, Hex:iPrOH 80:20, 1ml/min, UV 254nm, tr =
40.6 min, 47.0 min
Methyl (R)-2-(3-(2-benzoylbenzyl)-6-chloro-1-methyl-2-
oxoindolin-3-yl)acrylate 4b: Synthesized following the
general procedure described in Section 4.5. The product was
obtained as a red solid after flash chromatography on silica
gel using petroleum ether/EtOAc 9:1 as eluent. Yield 65%;
e.r. 70:30
HRMS calculated for [C27H22ClNO4]+H: 460.1316; found:
460.1299
[α]30D : (−16.6 ± 0.5)◦
1H NMR (400 MHz, Chloroform-d) δ 7.61 – 7.54 (m, 1H), 7.44 – 7.37 (m, 3H),
7.37 – 7.31 (m, 1H), 7.31 – 7.26 (m, 2H), 7.19 – 7.11 (m, 2H), 6.64 (s, 1H), 6.58 (d, J
= 7.9 Hz, 1H), 6.51 (d, J = 1.8 Hz, 1H), 6.31 (s, 1H), 6.11 (dd, J = 7.9, 1.9 Hz, 1H),
4.51 (d, J = 12.7 Hz, 1H), 3.53 (s, 3H), 3.38 (d, J = 12.6 Hz, 1H), 2.98 (s, 3H). 13C
NMR (101 MHz, Chloroform-d) δ 145.57, 139.92, 137.82, 136.97, 133.98, 132.94,
132.79, 130.32, 130.17, 128.12, 128.02, 127.97, 125.88, 124.49, 122.38, 108.22, 55.84,
52.11, 35.11, 26.21.
HPLC: Phenomenex Lux 5u Cellulose-4, Hex:iPrOH 80:20, 1ml/min, UV 254nm, tr =
13.3 min, 17.0 min
Methyl (R)-2-(3-(2-benzoylbenzyl)-5-fluoro-1-methyl-2-
oxoindolin-3-yl)acrylate 4c: Synthesized following the
general procedure described in Section 4.5. The product was
obtained as an orange solid after flash chromatography on
silica gel using petroleum ether/EtOAc 9:1 as eluent. Yield
78%; e.r. 72:28
HRMS calculated for [C27H22FNO4]+H: 444.1611; found:
444.1604
[α]30D : (−22.2 ± 0.2)◦
1H NMR (400 MHz, Chloroform-d) δ 7.48 (dt, J = 8.7, 4.4 Hz, 1H), 7.30 – 7.19
(m, 6H), 7.10 – 7.03 (m, 2H), 6.54 (s, 1H), 6.50 (td, J = 8.8, 2.6 Hz, 1H), 6.40 – 6.32
(m, 2H), 6.18 (s, 1H), 4.26 (d, J = 12.7 Hz, 1H), 3.44 (s, 3H), 3.34 (d, J = 12.7 Hz,
1H), 2.89 (s, 3H). 13C NMR (101 MHz, Chloroform-d) δ 197.28, 177.59, 165.18,
139.83, 138.07, 137.03, 134.83, 132.93, 132.71, 130.42, 130.16, 130.03, 128.14, 127.96,
125.91, 114.72, 114.48, 112.20, 111.95, 107.86, 107.78, 56.41, 52.10, 35.44, 26.27. 19F
NMR (376 MHz, Chloroform-d) δ -120.84.
HPLC: Phenomenex Lux 5u Cellulose-4, Hex:iPrOH 80:20, 1ml/min, UV 254nm, tr =
29.3 min, 33.7 min
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Methyl (R)-2-(3-(2-benzoylbenzyl)-1,5-dimethyl-2-oxoindolin-3-
yl)acrylate 4d: Synthesized following the general procedure
described in Section 4.5. The product was obtained as a
yellow solid after flash chromatography on silica gel using
petroleum ether/EtOAc 9:1 as eluent. Yield 55%; e.r. 69:31
HRMS calculated for [C28H25NO4]+H: 440.1862; found:
440.1831
[α]30D : (−9.4 ± 0.4)◦
1H NMR (400 MHz, Chloroform-d) δ 7.48 – 7.42 (m, 1H), 7.36 (d, J = 7.6 Hz,
1H), 7.26 – 7.18 (m, 3H), 7.14 (d, J = 7.2 Hz, 2H), 7.00 (ddd, J = 15.8, 7.4, 1.2 Hz,
2H), 6.58 (d, J = 7.8 Hz, 1H), 6.53 (s, 1H), 6.40 (s, 1H), 6.32 (d, J = 7.8 Hz, 1H), 6.20
(s, 1H), 4.45 (d, J = 12.5 Hz, 1H), 3.43 (s, 3H), 3.28 (d, J = 12.5 Hz, 1H), 2.89 (s,
3H), 1.38 (s, 3H). 13C NMR (101 MHz, Chloroform-d) δ 197.54, 165.35, 141.93,
140.45, 137.88, 137.35, 135.63, 133.02, 132.62, 132.49, 130.59, 130.41, 130.11, 128.68,
127.71, 127.56, 124.55, 107.12, 56.28, 52.00, 26.13, 20.21.
HPLC: Phenomenex Lux 5u Cellulose-4, Hex:iPrOH 80:20, 1ml/min, UV 254nm, tr =
12.6 min, 18.4 min
Methyl (R)-2-(3-(2-benzoyl-5-methylbenzyl)-1-methyl-2-
oxoindolin-3-yl)acrylate 4f: Synthesized following the
general procedure described in Section 4.5. The product was
obtained as a yellow solid after flash chromatography on
silica gel using petroleum ether/EtOAc 9:1 as eluent. Yield
58%; e.r. 70:30
HRMS calculated for [C28H25NO4]+H: 440.1862: found:
440.1853
[α]30D : (−2.9 ± 0.2)◦
1H NMR (400 MHz, Chloroform-d) δ 7.52 (tt, J = 7.8, 1.6 Hz, 1H), 7.37 – 7.27
(m, 4H), 7.13 (s, 1H), 7.03 – 6.89 (m, 3H), 6.73 (d, J = 7.3 Hz, 1H), 6.61 (s, 1H),
6.53 (d, J = 7.7 Hz, 1H), 6.36 (t, J = 7.5 Hz, 1H), 6.27 (s, 1H), 4.38 (d, J = 12.6 Hz,
1H), 3.51 (s, 3H), 3.42 (d, J = 12.6 Hz, 1H), 3.01 (s, 3H), 2.30 (s, 3H). 13C NMR
(101 MHz, Chloroform-d) δ 197.54, 165.35, 141.93, 140.45, 137.88, 137.35, 135.63,
133.02, 132.62, 132.49, 130.59, 130.41, 130.11, 129.69, 128.68, 127.71, 127.56, 125.61,
124.55, 107.12, 56.28, 52.00, 26.13, 20.21.
HPLC: Phenomenex Lux 5u Cellulose-5, Hex:iPrOH 80:20, 1ml/min, UV 254nm, tr =
34.9 min, 44.9 min
Methyl (R)-2-(3-(2-(4-bromobenzoyl)benzyl)-1-
methyl-2-oxoindolin-3-yl)acrylate 4g: Synthesized
following the general procedure described in Section
4.5. The product was obtained as a white solid after
flash chromatography on silica gel using petroleum
ether/EtOAc 9:1 as eluent. Yield 47%; e.r. 69:31
HRMS calculated for [C27H22BrNO4+H]: 504.0811;
found: 504.0804
[α]30D : (−17.8 ± 0.3)◦
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1H NMR (400 MHz, Chloroform-d) δ 7.46 (d, J = 8.5 Hz, 2H), 7.34 – 7.27 (m,
2H), 7.17 – 7.01 (m, 4H), 6.92 (t, J = 7.7 Hz, 1H), 6.71 (d, J = 7.3 Hz, 1H), 6.60
(s, 1H), 6.50 (d, J = 7.7 Hz, 1H), 6.34 (t, J = 7.5 Hz, 1H), 6.25 (s, 1H), 4.32 (d, J
= 12.6 Hz, 1H), 3.49 (s, 3H), 3.44 (d, J = 12.6 Hz, 1H), 2.96 (s, 3H). 13C NMR
(101 MHz, Chloroform-d) δ 196.28, 177.76, 144.45, 140.32, 137.62, 136.07, 135.36,
132.92, 132.11, 131.05, 130.20, 129.85, 129.81, 128.39, 127.76, 127.59, 125.80, 123.59,
122.46, 107.41, 56.12, 52.00, 35.41, 26.11.
HPLC: Phenomenex Lux 5u Cellulose-4, Hex:iPrOH 90:10, 1ml/min, UV 254nm, tr =
16.1 min, 25.8 min
Methyl (R)-2-(3-(2-benzoyl-4-bromobenzyl)-1-methyl-2-
oxoindolin-3-yl)acrylate 4h: Synthesized following the
general procedure described in Section 4.5. The product
was obtained as a white solid after flash chromatography on
silica gel using petroleum ether/EtOAc 9:1 as eluent. Yield
56%; e.r. 66:34
HRMS calculated for [C27H22BrNO4]+H: 504.0811; found:
504.0804
[α]30D : (−8.8 ± 1.2)◦
1H NMR (400 MHz, Chloroform-d) δ 7.54 (t, J = 7.3 Hz, 1H), 7.42 – 7.16 (m,
7H), 6.92 (td, J = 7.7, 1.0 Hz, 1H), 6.68 (d, J = 7.3 Hz, 1H), 6.59 – 6.52 (m, 2H), 6.30
(t, J = 7.5 Hz, 1H), 6.19 (s, 1H), 4.21 (d, J = 12.8 Hz, 1H), 3.48 (s, 3H), 3.38 (d, J =
12.8 Hz, 1H), 3.01 (s, 3H). 13C NMR (101 MHz, Chloroform-d) δ 195.76, 177.66,
165.23, 144.31, 140.25, 139.99, 136.58, 134.37, 134.27, 133.02, 132.84, 132.44, 130.57,
129.40, 128.58, 128.02, 123.57, 122.60, 119.87, 107.61, 52.02, 35.07, 26.23.
HPLC: Phenomenex Lux 5u Cellulose-1, Hex:iPrOH 95:5, 1ml/min, UV 254nm, tr =
24.6 min, 38.1 min
Methyl (R)-2-(3-(2-(2-fluorobenzoyl)benzyl)-1-methyl-2-
oxoindolin-3-yl)acrylate 4i: Synthesized following the
general procedure described in Section 4.5. The product
was obtained as a yellow solid after flash chromatogra-
phy on silica gel using petroleum ether/EtOAc 9:1 as
eluent. Yield 70%; e.r. 67:33
HRMS calculated for [C27H22FNO4]+H: 444.1611;
found: 444.1604
[α]30D : (−3.2 ± 0.6)◦
1H NMR (400 MHz, Chloroform-d) δ 7.55 – 7.44 (m, 1H), 7.32 – 7.22 (m, 2H),
7.18 – 7.00 (m, 6H), 6.90 (d, J = 7.3 Hz, 1H), 6.57 (dd, J = 17.5, 7.7 Hz, 3H), 6.29
(s, 1H), 4.51 (d, J = 12.6 Hz, 1H), 3.54 (d, J = 11.7 Hz, 4H), 2.99 (s, 3H). 13C (101
MHz, Chloroform-d) δ 194.14, 177.81, 165.38, 144.53, 140.46, 138.22, 135.52, 133.82,
133.73, 132.66, 132.44, 130.66, 130.60, 129.90, 128.37, 127.49, 126.13, 123.76, 123.50,
123.46, 122.20, 116.51, 116.29, 107.62, 56.23, 51.98, 35.27, 26.09. 19F NMR (376
MHz, Chloroform-d) δ -109.74.
HPLC: Phenomenex Lux 5u Cellulose-4, Hex:iPrOH 80:20, 1ml/min, UV 254nm, tr =
20.0 min, 33.4 min
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Ethyl (R)-2-(3-(2-benzoylbenzyl)-1-methyl-2-oxoindolin-3-
yl)acrylate 4j: Synthesized following the general procedure
described in Section 4.5. The product was obtained as a
white solid after flash chromatography on silica gel using
petroleum ether/EtOAc 9:1 as eluent. Yield 57%; e.r. 69:31
HRMS calculated for [C28H25NO4]+H: 440.1862; found:
440.1853
[α]30D : (−18.9 ± 2.1)◦
1H (400 MHz, Chloroform-d) δ 7.53 (t, J = 6.9 Hz, 1H), 7.33 (dt, J = 11.0, 7.7
Hz, 6H), 7.12 (d, J = 6.2 Hz, 2H), 6.92 (t, J = 7.2 Hz, 1H), 6.73 (d, J = 7.3 Hz, 1H),
6.63 (s, 1H), 6.51 (d, J = 7.7 Hz, 1H), 6.33 (t, J = 7.5 Hz, 1H), 6.23 (s, 1H), 4.34 (d,
J = 12.7 Hz, 1H), 3.98 – 3.82 (m, 2H), 3.47 (d, J = 12.6 Hz, 1H), 2.98 (s, 3H), 1.00 (t,
J = 7.1 Hz, 3H). 13C NMR (101 MHz, Chloroform-d) δ 197.35, 177.82, 164.98,
140.53, 138.17, 137.33, 135.29, 132.66, 132.57, 130.64, 130.11, 129.94, 129.90, 128.28,
127.76, 127.51, 125.71, 123.58, 122.52, 107.25, 60.79, 56.06, 26.05, 13.74.
HPLC: Phenomenex Lux 5u Cellulose-4, Hex:iPrOH 80:20, 1ml/min, UV 254nm, tr =
15.9 min, 25.2 min
Methyl (R)-2-(1-allyl-3-(2-benzoylbenzyl)-2-oxoindolin-3-
yl)acrylate 4k: Synthesized following the general procedure
described in Section 4.5. The product was obtained as an
orange solid after flash chromatography on silica gel using
petroleum ether/EtOAc 9:1 as eluent. Yield 52%; e.r. 70:30
HRMS calculated for [C29H25NO4]+H: 452.1862; found:
440.1859
[α]30D : (−17.8 ± 1.3)◦
1H NMR (400 MHz, Chloroform-d) δ 7.49 (tt, J = 5.7, 3.3 Hz, 1H), 7.35 – 7.24
(m, 6H), 7.16 – 7.07 (m, 2H), 6.81 (t, J = 7.3 Hz, 1H), 6.73 (d, J = 7.3 Hz, 1H), 6.59
(s, 1H), 6.49 (d, J = 7.8 Hz, 1H), 6.32 – 6.24 (m, 2H), 5.45 (ddt, J = 15.7, 10.4, 5.2
Hz, 1H), 5.07 – 4.99 (m, 1H), 4.84 – 4.76 (m, 1H), 4.41 – 4.27 (m, 2H), 3.97 (dd, J
= 16.5, 5.5 Hz, 1H), 3.50 (s, 4H). 13C NMR (101 MHz, Chloroform-d) δ 197.35,
177.40, 165.28, 143.80, 140.64, 138.27, 137.18, 135.28, 133.34, 132.52, 131.56, 130.63,
130.30, 130.14, 129.51, 128.28, 127.72, 127.47, 125.72, 123.82, 122.32, 117.15, 108.47,
56.05, 51.94, 42.53.
HPLC: Phenomenex Lux 5u Cellulose-4, Hex:iPrOH 80:20, 1ml/min, UV 254nm, tr =
16.1 min, 25.1 min
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4.8 Synthesis and characterisation of intermediates IIIa and IIIa’
(3R)-3-ethyl-5-(6-hydroxyquinolin-4-yl)-1-(3-methoxy-2-
((E)-1-methyl-2-oxoindolin-3-ylidene)-3-oxopropyl)-4-oxa-
1-azatricyclo[4.4.0.0]decan-1-ium IIIa: Synthesized by
mixing equimolar amount of methyl MBH carbonate 3a
(0.05 mmol, 1 equiv.) and β-isocupreidine (0.05 mmol,
1 equiv.) in methanol-d3 (0.5 mL, 0.1M) inside an NMR
tube. Quantitative formation of (E )-IIIa after 15 min.
HRMS calculated for [C32H33N3O5]+H: 540.2498,
found: 540.2534
1H NMR (400 MHz, Methanol-d3) δ 8.31 (d, J = 4.5 Hz, 1H), 7.66 (d, J = 4.5
Hz, 1H), 7.40 – 7.31 (m, 3H), 7.27 (d, J = 2.5 Hz, 1H), 7.13 – 7.04 (m, 2H), 6.81 (s,
1H), 6.48 (m, 2H), 4.69 (d, J = 13.1 Hz, 1H), 4.43 (d, J = 6.4 Hz, 1H), 4.36 (d, J =
12.6, 1H), 4.15 (s, 3H), 3.93 – 3.83 (m, 1H), 3.57(d, J = 12.5 Hz, 1H), 3.46 (dd, J =
11.8, 8.0 Hz, 1H), 2.96 (s, 3H), 2.51 (dd, J = 7.1, 3.9 Hz, 1H), 2.12 – 1.95 (m, 3H),
1.85 (dd, J = 13.5, 6.5 Hz, 1H), 1.77 (q, J = 7.4 Hz, 2H), 1.02 (t, J = 7.4 Hz, 3H). 13C
NMR (101 MHz, Methanol-d3) δ 169.0, 167.6, 145.4, 141.9, 139.5, 137.7, 134.2,
130.8, 127.8, 126.5, 125.8, 124.1, 119.9, 119.8, 109.9, 103.8, 77.6, 71.7, 71.3, 69.4, 60.8,
56.9, 55.5, 54.1, 32.7, 27.4, 26.0, 26.0, 23.4, 23.1, 7.1.
The MBH alcohol 6a (2 mmol) was treated with aqueous HBr 48% (1.4 mL) in the
presence of silica gel (670 mg) and heated at 40 ◦C for 24h. The mixture was then
filtered through a bed of Celite and washed with CH2Cl2 (15 mL). The organic layer
was collected, washed with brine and concentrated in vacuo to furnish the crude bro-
mide 7a. Purification by column chromatography on silica using hexane/EtOAc 7:3
as eluent afforded the pure bromide (E )-7a in 25% yield as a red solid. Subsequently,
the bromide 7a (3 mmol) was dissolved in THF (4 mL) and DABCO (1.1 equiv.) was
added to the solution. The mixture was then stirred at room temperature for 5h, the
salt IIIa’ was purified by filtration and the filtrate was washed with Et2O. (E )-IIIa’
was obtained in 45% yield as an orange solid.57
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(E)-1-(3-methoxy-2-(1-methyl-2-oxoindolin-3-ylidene)-3-oxopropyl)-
1,4-diazabicyclo[2.2.2] octan-1-ium IIIa’: 1H NMR (400 MHz,
Methanol-d3) δ 7.56 – 7.42 (m, 2H), 7.11 – 6.98 (m, 2H), 5.09
(s, H), 4.06 (s, 3H), 3.52 (t, J = 7.5 Hz, 6H), 3.25 – 3.16 (m, 9H).
13C NMR (101 MHz, Methanol-d3) δ 168.88, 167.56, 146.16,
137.59, 134.41, 126.67, 126.06, 123.98, 120.15, 110.28, 54.21,
53.93, 46.12, 26.41. HRMS calculated for [C19H24N3O3]+H:
342.1812, found: 342.1821
Figure 4.4: Setup for the photochemical semi-continuous 1H NMR experiments used in
this work to monitor the photoisomerization of the catalytic species.
4.9 X-Ray Structure and Absolute Configuration of Compound 4a
Crystals were prepared by dissolving compound 4a in dichloromethane and freezing
the solution. Three different vials were prepared with three different solvents: hex-
ane, cyclohexane and toluene. Crystals were formed with hexane and cyclohexane and
in particular the ones with hexane were used to resolve the crystal structure. The
molecule crystallizes with a CH2CL2 molecule, as shown in Figure 4.5. X-ray structure
was resolved thanks to Dr Marzio Rancan from University of Padova.
Data were collected using an Oxford Diffraction Gemini E diffractometer, equipped
with a 2K×2K EOS CCD area detector using a sealed–tube Enhance (Mo) source.
A suitable single crystal of the compound was fastened on the top of a Lindemann
glass capillary. Data were collected by means of the ω-scans technique using graphite-
monochromated radiation. Detector distance has been set at 45mm. The diffraction
intensities were corrected for Lorentz/polarization effects as well as with respect to ab-
sorption. Empirical multi-scan absorption corrections using equivalent reflections were
performed with the scaling algorithm SCALE3 ABSPACK. Data reduction, finalization
and cell refinement were carried out through the CrysAlisPro software. Accurate unit
cell parameters were obtained by least squares refinement of the angular settings of
strongest reflections, chosen from the whole experiment. The structures were solved
with Olex2 by using ShelXT structure solution program by Intrinsic Phasing and re-
fined with the ShelXL refinement package using least-squares minimization. In the last
cycles of refinement, non-hydrogen atoms were refined anisotropically. Hydrogen atoms
were included in calculated positions, and a riding model was used for their refinement.
A solvent molecule (CH2Cl2) was disordered over two sites, the occupancies of which
were constrained to sum to 1.0. This disordered molecule was modelled using SADI and
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RIGU restraints. EADP constrain was applied to atoms C28A/C28B and Cl1A/Cl1B.
The specific refinement details have been deposited at the Cambridge Crystallographic
Data Centre (CCDC 1960705).
Figure 4.5: Crystal structure of compound 4a. Thermal ellipsoids drawn at the 50%
probability level. H atoms omitted for clarity.
It was not possible to obtain the absolute configuration by x-ray diffraction because the
crystals obtained were racemates. The absolute configuration was determined thanks to
Prof. Andrea Mazzanti from University of Bologna, by theoretical simulations of chiro-
optical spectra (electronic circular dichroism, ECD). Comparing the measured circular
dichroism of 4a (e.r. 70:30) with the one calculated by DFT, the determination of the
absolute configuration was possible. Results show that for 4a the major enantiomer is
the (R)-enantiomer, and so it is, for similarity, for all the other compounds. Comparison
between the theoretical and the experimental ECD are shown in Figure 4.7.
Figure 4.6: Measured UV and ECD spectra of 4a 10−4M in acetonitrile.
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Figure 4.7: Left: TD-DFT simulated spectra calculated for the best seven conforma-
tions of 4a (R absolute configuration) using CAM-B3LYP/6-311++G(2d,p) basis set.
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Un grazie ancora più grande va ai miei sponsor ufficiali dal 1995, nonché miei più grandi
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